_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,direction,b1,b2,direction_gold,e1,e2,relation,relex_relcos,sent_id,sentence,term1,term2,twrex
789214457,9/16/2015 12:47:33,1739495084,9/16/2015 12:47:15,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,HTLV III/LAV treats AIDS,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 13:33:22,1739509739,9/16/2015 13:29:27,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,no_relation,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:01:36,1739520806,9/16/2015 14:01:15,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,HTLV III/LAV treats AIDS,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:16:23,1739525974,9/16/2015 14:15:05,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,no_relation,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:20:40,1739527496,9/16/2015 14:20:18,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,HTLV III/LAV treats AIDS,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:29:44,1739530604,9/16/2015 14:29:20,false,onestopgpt,0.8333,21275875,CAN,ON,Hamilton,24.36.124.79,no_relation,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214457,9/16/2015 14:34:49,1739532521,9/16/2015 14:33:55,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,HTLV III/LAV treats AIDS,147,104,,150,116,treats,0.6,812467,"Yarchoan R, Klecker RE, Weinhold KJ et al Administration of 3′ azido 3′ deoxythymidine, an inhibitor of HTLV III/LAV replication, to patients with AIDS or AIDS related complex.",AIDS,HTLV III/LAV,TWrex-cause
789214458,9/16/2015 11:32:04,1739475706,9/16/2015 11:31:54,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 11:42:46,1739478428,9/16/2015 11:42:34,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,HYPERTENSION treats PROPRANOLOL,98,73,,109,84,treats,0.963086824686154,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 11:46:11,1739479290,9/16/2015 11:45:56,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 12:03:50,1739483495,9/16/2015 12:03:35,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 12:14:51,1739486159,9/16/2015 12:14:22,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,no_relation,98,73,,109,84,treats,0.963086824686154,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 12:16:12,1739486570,9/16/2015 12:15:56,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214458,9/16/2015 12:29:49,1739489575,9/16/2015 12:29:36,false,instagc,0.8397,13581319,USA,IL,Trenton,208.70.36.12,PROPRANOLOL treats HYPERTENSION,98,73,,109,84,treats,0.963086824686154,907590,"van Schaik BAM, Geyskes GG, Kettner N et al. Comparison of enalapril and PROPRANOLOL in essential HYPERTENSION",HYPERTENSION,PROPRANOLOL,RO-may_treat
789214459,9/16/2015 15:55:39,1739574784,9/16/2015 15:55:13,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 16:16:15,1739584227,9/16/2015 16:15:52,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 16:39:15,1739594332,9/16/2015 16:39:03,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 16:52:18,1739600722,9/16/2015 16:52:07,false,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 16:52:20,1739600731,9/16/2015 16:52:13,false,prodege,0.2,2143114,CAN,BC,Vancouver,24.85.153.181,HYPERTENSION treats DOXAZOSIN,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 17:12:53,1739610907,9/16/2015 17:12:45,false,superrewards,0.8333,33199643,USA,WI,La Crosse,138.49.2.136,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214459,9/16/2015 17:24:23,1739615930,9/16/2015 17:23:54,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,DOXAZOSIN treats HYPERTENSION,50,25,,61,34,treats,0.99654575824488,908046,He took a 1 mg tablet of DOXAZOSIN daily for mild HYPERTENSION,HYPERTENSION,DOXAZOSIN,RO-may_treat
789214460,9/16/2015 14:48:23,1739537728,9/16/2015 14:48:06,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,MESNA treats HAEMATURIA,83,0,,93,5,treats,0.997054485501581,220426,[MESNA] is used therapeutically to reduce the incidence of haemorrhagic cystitis and [HAEMATURIA] when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy.,HAEMATURIA,MESNA,TWrex-treat
789214460,9/16/2015 14:59:41,1739542379,9/16/2015 14:59:25,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,MESNA treats HAEMATURIA,83,0,,93,5,treats,0.997054485501581,220426,[MESNA] is used therapeutically to reduce the incidence of haemorrhagic cystitis and [HAEMATURIA] when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy.,HAEMATURIA,MESNA,TWrex-treat
789214460,9/16/2015 15:06:52,1739545287,9/16/2015 15:05:18,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,no_relation,83,0,,93,5,treats,0.997054485501581,220426,[MESNA] is used therapeutically to reduce the incidence of haemorrhagic cystitis and [HAEMATURIA] when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy.,HAEMATURIA,MESNA,TWrex-treat
789214460,9/16/2015 15:12:56,1739547780,9/16/2015 15:11:52,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,MESNA treats HAEMATURIA,83,0,,93,5,treats,0.997054485501581,220426,[MESNA] is used therapeutically to reduce the incidence of haemorrhagic cystitis and [HAEMATURIA] when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy.,HAEMATURIA,MESNA,TWrex-treat
789214460,9/16/2015 15:13:28,1739547996,9/16/2015 15:13:02,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,HAEMATURIA treats MESNA,83,0,,93,5,treats,0.997054485501581,220426,[MESNA] is used therapeutically to reduce the incidence of haemorrhagic cystitis and [HAEMATURIA] when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy.,HAEMATURIA,MESNA,TWrex-treat
789214460,9/16/2015 15:14:42,1739548549,9/16/2015 15:13:50,false,clixsense,0.3143,6336109,CAN,BC,Prince George,198.254.211.52,no_relation,83,0,,93,5,treats,0.997054485501581,220426,[MESNA] is used therapeutically to reduce the incidence of haemorrhagic cystitis and [HAEMATURIA] when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy.,HAEMATURIA,MESNA,TWrex-treat
789214460,9/16/2015 15:30:35,1739562610,9/16/2015 15:30:14,false,tremorgames,0.5357,24449707,CAN,QC,Laval,96.20.14.148,no_relation,83,0,,93,5,treats,0.997054485501581,220426,[MESNA] is used therapeutically to reduce the incidence of haemorrhagic cystitis and [HAEMATURIA] when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy.,HAEMATURIA,MESNA,TWrex-treat
789214461,9/16/2015 09:41:50,1739444631,9/16/2015 09:38:18,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 09:44:55,1739445278,9/16/2015 09:44:42,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 09:52:23,1739447176,9/16/2015 09:51:54,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 09:54:25,1739447780,9/16/2015 09:54:07,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 09:54:32,1739447820,9/16/2015 09:54:09,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 10:07:41,1739452055,9/16/2015 10:06:00,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214461,9/16/2015 10:13:29,1739453692,9/16/2015 10:11:53,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,HYPERTHERMIA treats HEPATOCELLULAR CARCINOMA,85,141,,96,165,treats,0.975900072948533,902641,This anecdotal case supports previous experimental evidence suggesting that TNF plus HYPERTHERMIA may be effective for treating unresectable HEPATOCELLULAR CARCINOMA,HYPERTHERMIA,HEPATOCELLULAR CARCINOMA,RO-disease_may_have_finding
789214462,9/16/2015 12:45:20,1739494278,9/16/2015 12:45:06,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 12:47:14,1739495018,9/16/2015 12:46:49,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,no_relation,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 13:29:25,1739508510,9/16/2015 13:28:11,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 13:41:49,1739514436,9/16/2015 13:40:59,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 13:53:49,1739518214,9/16/2015 13:53:24,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 14:01:12,1739520658,9/16/2015 14:00:13,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214462,9/16/2015 14:20:16,1739527363,9/16/2015 14:11:17,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,DISOPYRAMIDE treats VENTRICULAR TACHYCARDIA,233,257,,255,269,treats,0.609994281330419,907380,"In 75% of supraventricular parossistic tachycardia and in 75% of parossistic atrial fibrillation, arrhythmia was interrupted within few minutes from drug injection; in 90% with premature ventricular contractions (PVC) and in 100% of VENTRICULAR TACHYCARDIA DISOPYRAMIDE was capable to interrupt the arrhythmias.",VENTRICULAR TACHYCARDIA,DISOPYRAMIDE,RO-may_prevent
789214463,9/16/2015 12:04:59,1739483809,9/16/2015 12:04:31,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,METFORMIN treats TYPE 2 DIABETES,97,140,,111,149,treats,0.995893206467704,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN,TWrex-cause
789214463,9/16/2015 12:18:37,1739487110,9/16/2015 12:18:02,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,METFORMIN treats TYPE 2 DIABETES,97,140,,111,149,treats,0.995893206467704,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN,TWrex-cause
789214463,9/16/2015 12:43:52,1739493796,9/16/2015 12:43:25,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,METFORMIN treats TYPE 2 DIABETES,97,140,,111,149,treats,0.995893206467704,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN,TWrex-cause
789214463,9/16/2015 12:45:46,1739494384,9/16/2015 12:45:26,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,METFORMIN treats TYPE 2 DIABETES,97,140,,111,149,treats,0.995893206467704,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN,TWrex-cause
789214463,9/16/2015 12:53:47,1739497032,9/16/2015 12:53:38,false,instagc,0.8661,15577915,USA,IL,Trenton,208.70.36.12,METFORMIN treats TYPE 2 DIABETES,97,140,,111,149,treats,0.995893206467704,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN,TWrex-cause
789214463,9/16/2015 13:22:17,1739506455,9/16/2015 13:20:43,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,METFORMIN treats TYPE 2 DIABETES,97,140,,111,149,treats,0.995893206467704,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN,TWrex-cause
789214463,9/16/2015 13:38:00,1739513089,9/16/2015 13:37:22,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,METFORMIN treats TYPE 2 DIABETES,97,140,,111,149,treats,0.995893206467704,800103,"STUDY SELECTION  Clinical trials and cohort studies were selected if they included patients with TYPE 2 DIABETES lasted ≥ 1 month, compared METFORMIN alone or combined with other treatments with placebo or any other hypoglycemic therapy, and reported the number of patients and duration of treatment.",TYPE 2 DIABETES,METFORMIN,TWrex-cause
789214464,9/16/2015 18:00:15,1739639054,9/16/2015 17:59:42,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 18:17:29,1739665842,9/16/2015 18:16:12,false,elite,0.875,31883685,GBR,"","",79.66.244.188,SVT treats SOTALOL,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 18:24:54,1739680870,9/16/2015 18:23:58,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 18:28:51,1739689632,9/16/2015 18:27:46,false,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 18:54:38,1739753561,9/16/2015 18:53:30,false,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 19:07:40,1739773585,9/16/2015 19:06:53,false,neodev,0.704,11026968,CAN,ON,Ottawa,108.168.124.170,no_relation,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214464,9/16/2015 19:27:43,1739783444,9/16/2015 19:27:18,false,clixsense,0.8036,23197581,NLD,11,Den Haag,82.217.6.160,SOTALOL treats SVT,0,89,,2,96,treats,0.986393923832144,805021,SVT that does not involve the AV node may respond to other anti arrhythmic drugs such as SOTALOL or amiodarone.,SVT,SOTALOL,TWrex-cause
789214465,9/16/2015 11:05:00,1739469245,9/16/2015 11:04:45,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,ORLISTAT treats OBESITY,39,0,,45,8,treats,0.99654575824488,803599,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT,TWrex-cause
789214465,9/16/2015 11:09:24,1739470290,9/16/2015 11:08:52,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,ORLISTAT treats OBESITY,39,0,,45,8,treats,0.99654575824488,803599,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT,TWrex-cause
789214465,9/16/2015 11:19:21,1739472989,9/16/2015 11:19:04,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,ORLISTAT treats OBESITY,39,0,,45,8,treats,0.99654575824488,803599,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT,TWrex-cause
789214465,9/16/2015 11:20:11,1739473204,9/16/2015 11:19:53,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,ORLISTAT treats OBESITY,39,0,,45,8,treats,0.99654575824488,803599,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT,TWrex-cause
789214465,9/16/2015 11:26:26,1739474425,9/16/2015 11:25:41,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,ORLISTAT treats OBESITY,39,0,,45,8,treats,0.99654575824488,803599,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT,TWrex-cause
789214465,9/16/2015 11:26:52,1739474470,9/16/2015 11:26:27,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,ORLISTAT treats OBESITY,39,0,,45,8,treats,0.99654575824488,803599,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT,TWrex-cause
789214465,9/16/2015 11:29:47,1739475202,9/16/2015 11:26:12,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,ORLISTAT treats OBESITY,39,0,,45,8,treats,0.99654575824488,803599,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT,TWrex-cause
789214466,9/16/2015 14:01:53,1739520847,9/16/2015 14:01:36,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:17:18,1739526265,9/16/2015 14:16:24,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:20:53,1739527572,9/16/2015 14:20:40,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:29:54,1739530698,9/16/2015 14:29:45,false,onestopgpt,0.8333,21275875,CAN,ON,Hamilton,24.36.124.79,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:35:18,1739532680,9/16/2015 14:34:49,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:38:53,1739534038,9/16/2015 14:37:53,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,INSULIN ASPART treats TYPE 1 DIABETES,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214466,9/16/2015 14:43:10,1739535717,9/16/2015 14:43:02,false,neodev,0.1429,11291592,USA,MI,Taylor,99.170.106.105,no_relation,157,68,,171,82,treats,0.99654575824488,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN ASPART,TWrex-cause
789214467,9/16/2015 11:05:14,1739469284,9/16/2015 11:05:02,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,MIDODRINE (PROAMATINE treats ORTHOSTATIC HYPOTENSION,90,0,,112,21,treats,0.993127066322842,800957,MIDODRINE (PROAMATINE is approved by the U.S. Food and Drug Administration (FDA) to treat ORTHOSTATIC HYPOTENSION a condition related to POTS.,ORTHOSTATIC HYPOTENSION,MIDODRINE (PROAMATINE,TWrex-cause
789214467,9/16/2015 11:10:01,1739470392,9/16/2015 11:09:25,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,MIDODRINE (PROAMATINE treats ORTHOSTATIC HYPOTENSION,90,0,,112,21,treats,0.993127066322842,800957,MIDODRINE (PROAMATINE is approved by the U.S. Food and Drug Administration (FDA) to treat ORTHOSTATIC HYPOTENSION a condition related to POTS.,ORTHOSTATIC HYPOTENSION,MIDODRINE (PROAMATINE,TWrex-cause
789214467,9/16/2015 11:19:47,1739473070,9/16/2015 11:19:22,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,MIDODRINE (PROAMATINE treats ORTHOSTATIC HYPOTENSION,90,0,,112,21,treats,0.993127066322842,800957,MIDODRINE (PROAMATINE is approved by the U.S. Food and Drug Administration (FDA) to treat ORTHOSTATIC HYPOTENSION a condition related to POTS.,ORTHOSTATIC HYPOTENSION,MIDODRINE (PROAMATINE,TWrex-cause
789214467,9/16/2015 11:20:35,1739473328,9/16/2015 11:20:14,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,MIDODRINE (PROAMATINE treats ORTHOSTATIC HYPOTENSION,90,0,,112,21,treats,0.993127066322842,800957,MIDODRINE (PROAMATINE is approved by the U.S. Food and Drug Administration (FDA) to treat ORTHOSTATIC HYPOTENSION a condition related to POTS.,ORTHOSTATIC HYPOTENSION,MIDODRINE (PROAMATINE,TWrex-cause
789214467,9/16/2015 11:26:49,1739474459,9/16/2015 11:26:27,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,MIDODRINE (PROAMATINE treats ORTHOSTATIC HYPOTENSION,90,0,,112,21,treats,0.993127066322842,800957,MIDODRINE (PROAMATINE is approved by the U.S. Food and Drug Administration (FDA) to treat ORTHOSTATIC HYPOTENSION a condition related to POTS.,ORTHOSTATIC HYPOTENSION,MIDODRINE (PROAMATINE,TWrex-cause
789214467,9/16/2015 11:27:11,1739474580,9/16/2015 11:26:56,false,elite,0.5833,33798502,USA,DE,"",108.59.8.208,MIDODRINE (PROAMATINE treats ORTHOSTATIC HYPOTENSION,90,0,,112,21,treats,0.993127066322842,800957,MIDODRINE (PROAMATINE is approved by the U.S. Food and Drug Administration (FDA) to treat ORTHOSTATIC HYPOTENSION a condition related to POTS.,ORTHOSTATIC HYPOTENSION,MIDODRINE (PROAMATINE,TWrex-cause
789214467,9/16/2015 11:27:53,1739474789,9/16/2015 11:26:53,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,MIDODRINE (PROAMATINE treats ORTHOSTATIC HYPOTENSION,90,0,,112,21,treats,0.993127066322842,800957,MIDODRINE (PROAMATINE is approved by the U.S. Food and Drug Administration (FDA) to treat ORTHOSTATIC HYPOTENSION a condition related to POTS.,ORTHOSTATIC HYPOTENSION,MIDODRINE (PROAMATINE,TWrex-cause
789214468,9/16/2015 17:38:37,1739624574,9/16/2015 17:38:24,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,no_relation,38,196,,62,216,treats,0.881917103688197,907921,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
789214468,9/16/2015 17:53:53,1739631744,9/16/2015 17:53:27,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,no_relation,38,196,,62,216,treats,0.881917103688197,907921,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
789214468,9/16/2015 17:59:21,1739637905,9/16/2015 17:58:53,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,CYTOSINE ARABINOSIDE treats ACUTE MYELOCYTIC LEUKEMIA,38,196,,62,216,treats,0.881917103688197,907921,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
789214468,9/16/2015 18:15:51,1739662824,9/16/2015 18:15:16,false,elite,0.875,31883685,GBR,"","",79.66.244.188,ACUTE MYELOCYTIC LEUKEMIA treats CYTOSINE ARABINOSIDE,38,196,,62,216,treats,0.881917103688197,907921,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
789214468,9/16/2015 18:23:27,1739677836,9/16/2015 18:23:05,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,38,196,,62,216,treats,0.881917103688197,907921,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
789214468,9/16/2015 18:27:20,1739686236,9/16/2015 18:26:55,false,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,CYTOSINE ARABINOSIDE treats ACUTE MYELOCYTIC LEUKEMIA,38,196,,62,216,treats,0.881917103688197,907921,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
789214468,9/16/2015 18:52:35,1739748322,9/16/2015 18:50:52,false,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,CYTOSINE ARABINOSIDE treats ACUTE MYELOCYTIC LEUKEMIA,38,196,,62,216,treats,0.881917103688197,907921,"CASE SCENARIO  A 30 year old man with ACUTE MYELOCYTIC LEUKEMIA failed to respond to induction therapy with cytosine arabinoside and idarubicin and received salvage chemotherapy with fludarabine, CYTOSINE ARABINOSIDE, G CSF, and idarubicin.",ACUTE MYELOCYTIC LEUKEMIA,CYTOSINE ARABINOSIDE,RO-may_treat
789214469,9/16/2015 11:11:02,1739470584,9/16/2015 11:10:33,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,ARSENIC TRIOXIDE treats APL,181,43,,183,59,treats,1,803784,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE,TWrex-cause
789214469,9/16/2015 11:22:18,1739473688,9/16/2015 11:21:50,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,no_relation,181,43,,183,59,treats,1,803784,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE,TWrex-cause
789214469,9/16/2015 11:28:36,1739474917,9/16/2015 11:27:45,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,ARSENIC TRIOXIDE treats APL,181,43,,183,59,treats,1,803784,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE,TWrex-cause
789214469,9/16/2015 11:30:36,1739475421,9/16/2015 11:29:41,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,ARSENIC TRIOXIDE treats APL,181,43,,183,59,treats,1,803784,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE,TWrex-cause
789214469,9/16/2015 11:30:46,1739475451,9/16/2015 11:30:31,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,APL treats ARSENIC TRIOXIDE,181,43,,183,59,treats,1,803784,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE,TWrex-cause
789214469,9/16/2015 11:33:42,1739476102,9/16/2015 11:33:25,false,clixsense,0.9111,21490235,GBR,N7,Woking,86.30.254.232,ARSENIC TRIOXIDE treats APL,181,43,,183,59,treats,1,803784,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE,TWrex-cause
789214469,9/16/2015 11:40:35,1739477892,9/16/2015 11:33:08,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,ARSENIC TRIOXIDE treats APL,181,43,,183,59,treats,1,803784,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE,TWrex-cause
789214470,9/16/2015 10:15:28,1739454370,9/16/2015 10:14:59,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,RIFAMPIN treats TUBERCULOSIS,9,55,,20,63,treats,0.603022689155527,804913,258 •   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN,TWrex-cause
789214470,9/16/2015 10:44:51,1739463038,9/16/2015 10:44:17,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,no_relation,9,55,,20,63,treats,0.603022689155527,804913,258 •   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN,TWrex-cause
789214470,9/16/2015 10:46:09,1739463437,9/16/2015 10:45:42,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,RIFAMPIN treats TUBERCULOSIS,9,55,,20,63,treats,0.603022689155527,804913,258 •   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN,TWrex-cause
789214470,9/16/2015 10:51:17,1739465079,9/16/2015 10:51:04,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,TUBERCULOSIS treats RIFAMPIN,9,55,,20,63,treats,0.603022689155527,804913,258 •   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN,TWrex-cause
789214470,9/16/2015 11:01:42,1739468301,9/16/2015 11:01:25,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,no_relation,9,55,,20,63,treats,0.603022689155527,804913,258 •   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN,TWrex-cause
789214470,9/16/2015 11:04:18,1739469031,9/16/2015 11:03:57,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,no_relation,9,55,,20,63,treats,0.603022689155527,804913,258 •   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN,TWrex-cause
789214470,9/16/2015 11:13:54,1739471433,9/16/2015 11:07:25,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,9,55,,20,63,treats,0.603022689155527,804913,258 •   MTUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,TUBERCULOSIS,RIFAMPIN,TWrex-cause
789214471,9/16/2015 14:01:53,1739520851,9/16/2015 14:01:36,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:17:18,1739526264,9/16/2015 14:16:24,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:20:53,1739527574,9/16/2015 14:20:40,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:29:54,1739530703,9/16/2015 14:29:45,false,onestopgpt,0.8333,21275875,CAN,ON,Hamilton,24.36.124.79,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:35:18,1739532678,9/16/2015 14:34:49,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:38:53,1739534042,9/16/2015 14:37:53,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,BUPRENORPHINE HYDROCHLORIDE treats POST OPERATIVE PAIN,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214471,9/16/2015 14:43:10,1739535714,9/16/2015 14:43:02,false,neodev,0.1429,11291592,USA,MI,Taylor,99.170.106.105,no_relation,93,61,,111,88,treats,0.753778361444409,800578,"Dobkin AB, Esposito B, Philbin C. Double blind evaluation of BUPRENORPHINE HYDROCHLORIDE for POST OPERATIVE PAIN",POST OPERATIVE PAIN,BUPRENORPHINE HYDROCHLORIDE,TWrex-cause
789214472,9/16/2015 10:46:50,1739463639,9/16/2015 10:46:10,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.953998092005724,907799,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
789214472,9/16/2015 10:51:29,1739465157,9/16/2015 10:51:17,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.953998092005724,907799,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
789214472,9/16/2015 11:04:44,1739469139,9/16/2015 11:04:20,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.953998092005724,907799,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
789214472,9/16/2015 11:08:50,1739470197,9/16/2015 11:07:58,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,no_relation,53,135,,58,146,treats,0.953998092005724,907799,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
789214472,9/16/2015 11:19:03,1739472908,9/16/2015 11:18:27,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.953998092005724,907799,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
789214472,9/16/2015 11:19:52,1739473093,9/16/2015 11:19:19,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.953998092005724,907799,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
789214472,9/16/2015 11:26:09,1739474369,9/16/2015 11:25:09,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,MONTELUKAST treats ASTHMA,53,135,,58,146,treats,0.953998092005724,907799,Because montelukast is efficacious for patients with ASTHMA selected patients with mild asthma and rhinitis may be good candidates for MONTELUKAST.,ASTHMA,MONTELUKAST,RO-may_treat
789214473,9/16/2015 14:18:29,1739526672,9/16/2015 14:17:19,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,no_relation,169,67,,176,76,treats,0.625,219195,"Other medications which may be effective include: fludrocortisone, [MIDODRINE], SSRIs such as paroxetine or sertraline, disopyramide, and, in health-care settings where a [SYNCOPE] is anticipated, atropine.",SYNCOPE,MIDODRINE,TWrex-treat
789214473,9/16/2015 14:21:14,1739527695,9/16/2015 14:20:55,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,MIDODRINE treats SYNCOPE,169,67,,176,76,treats,0.625,219195,"Other medications which may be effective include: fludrocortisone, [MIDODRINE], SSRIs such as paroxetine or sertraline, disopyramide, and, in health-care settings where a [SYNCOPE] is anticipated, atropine.",SYNCOPE,MIDODRINE,TWrex-treat
789214473,9/16/2015 14:36:14,1739533002,9/16/2015 14:35:19,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,MIDODRINE treats SYNCOPE,169,67,,176,76,treats,0.625,219195,"Other medications which may be effective include: fludrocortisone, [MIDODRINE], SSRIs such as paroxetine or sertraline, disopyramide, and, in health-care settings where a [SYNCOPE] is anticipated, atropine.",SYNCOPE,MIDODRINE,TWrex-treat
789214473,9/16/2015 14:43:55,1739536009,9/16/2015 14:38:53,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,169,67,,176,76,treats,0.625,219195,"Other medications which may be effective include: fludrocortisone, [MIDODRINE], SSRIs such as paroxetine or sertraline, disopyramide, and, in health-care settings where a [SYNCOPE] is anticipated, atropine.",SYNCOPE,MIDODRINE,TWrex-treat
789214473,9/16/2015 14:54:53,1739540421,9/16/2015 14:54:05,false,bitcoinget,0.7375,20311164,NLD,09,Utrecht,84.105.54.251,no_relation,169,67,,176,76,treats,0.625,219195,"Other medications which may be effective include: fludrocortisone, [MIDODRINE], SSRIs such as paroxetine or sertraline, disopyramide, and, in health-care settings where a [SYNCOPE] is anticipated, atropine.",SYNCOPE,MIDODRINE,TWrex-treat
789214473,9/16/2015 14:57:22,1739541459,9/16/2015 14:55:32,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,MIDODRINE treats SYNCOPE,169,67,,176,76,treats,0.625,219195,"Other medications which may be effective include: fludrocortisone, [MIDODRINE], SSRIs such as paroxetine or sertraline, disopyramide, and, in health-care settings where a [SYNCOPE] is anticipated, atropine.",SYNCOPE,MIDODRINE,TWrex-treat
789214473,9/16/2015 15:00:12,1739542690,9/16/2015 14:58:44,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,MIDODRINE treats SYNCOPE,169,67,,176,76,treats,0.625,219195,"Other medications which may be effective include: fludrocortisone, [MIDODRINE], SSRIs such as paroxetine or sertraline, disopyramide, and, in health-care settings where a [SYNCOPE] is anticipated, atropine.",SYNCOPE,MIDODRINE,TWrex-treat
789214474,9/16/2015 14:20:30,1739527421,9/16/2015 14:19:24,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,HYOSCYAMINE treats PANCREATITIS,163,0,,175,11,treats,1,210991,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, [PANCREATITIS], colic and cystitis.",PANCREATITIS,HYOSCYAMINE,TWrex-treat
789214474,9/16/2015 14:37:29,1739533517,9/16/2015 14:36:55,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,HYOSCYAMINE treats PANCREATITIS,163,0,,175,11,treats,1,210991,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, [PANCREATITIS], colic and cystitis.",PANCREATITIS,HYOSCYAMINE,TWrex-treat
789214474,9/16/2015 14:47:47,1739537506,9/16/2015 14:44:52,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,HYOSCYAMINE treats PANCREATITIS,163,0,,175,11,treats,1,210991,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, [PANCREATITIS], colic and cystitis.",PANCREATITIS,HYOSCYAMINE,TWrex-treat
789214474,9/16/2015 14:58:45,1739541952,9/16/2015 14:57:55,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,HYOSCYAMINE treats PANCREATITIS,163,0,,175,11,treats,1,210991,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, [PANCREATITIS], colic and cystitis.",PANCREATITIS,HYOSCYAMINE,TWrex-treat
789214474,9/16/2015 15:03:59,1739544291,9/16/2015 15:02:39,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,no_relation,163,0,,175,11,treats,1,210991,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, [PANCREATITIS], colic and cystitis.",PANCREATITIS,HYOSCYAMINE,TWrex-treat
789214474,9/16/2015 15:10:33,1739546762,9/16/2015 15:09:13,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,HYOSCYAMINE treats PANCREATITIS,163,0,,175,11,treats,1,210991,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, [PANCREATITIS], colic and cystitis.",PANCREATITIS,HYOSCYAMINE,TWrex-treat
789214474,9/16/2015 15:49:26,1739571950,9/16/2015 15:49:10,false,instagc,0.7897,33467170,USA,WV,Martinsburg,76.106.109.7,HYOSCYAMINE treats PANCREATITIS,163,0,,175,11,treats,1,210991,"[HYOSCYAMINE] is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, diverticulitis, [PANCREATITIS], colic and cystitis.",PANCREATITIS,HYOSCYAMINE,TWrex-treat
789214475,9/16/2015 15:56:03,1739574983,9/16/2015 15:55:40,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 16:16:36,1739584331,9/16/2015 16:16:19,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 16:39:27,1739594400,9/16/2015 16:39:17,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 16:52:25,1739600738,9/16/2015 16:52:19,false,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 17:25:13,1739616345,9/16/2015 17:24:24,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 17:28:45,1739618763,9/16/2015 17:27:35,false,neodev,1.0,23017572,USA,CA,Santa Ana,67.215.241.18,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214475,9/16/2015 17:37:06,1739623949,9/16/2015 17:36:42,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,ERGONOVINE treats VARIANT ANGINA,26,58,,40,68,treats,0.957427107756338,500145,"However, in patients with VARIANT ANGINA, a small dose of ERGONOVINE produced a percentage of change in diameter of 39.8 +/- 15.3% at the site of spastic occlusion included by a larger dose of ergonovine, compared with that of 7.0 +/- 11.9% in the remaining non-spastic coronary arteries (p less than 0.05",VARIANT ANGINA,ERGONOVINE,TWrex-diagnose
789214476,9/16/2015 10:14:42,1739454084,9/16/2015 10:14:19,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:15:57,1739454587,9/16/2015 10:15:20,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:18:07,1739455384,9/16/2015 10:17:30,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:43:44,1739462675,9/16/2015 10:42:48,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:45:02,1739463096,9/16/2015 10:44:26,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 10:50:15,1739464687,9/16/2015 10:46:57,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,DIMETHYLGLYCINE treats AUTISTIC BEHAVIOR,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214476,9/16/2015 11:01:04,1739468051,9/16/2015 11:00:52,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,no_relation,61,0,,78,15,treats,0.997458699830735,205470,"[DIMETHYLGLYCINE] is hypothesized to improve speech and reduce [AUTISTIC BEHAVIOR]s, and is a commonly used supplement.",AUTISTIC BEHAVIOR,DIMETHYLGLYCINE,TWrex-treat
789214477,9/16/2015 11:31:41,1739475636,9/16/2015 11:31:20,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,FLUMAZENIL treats OPIOID OVERDOSE,136,162,,151,172,treats,0.492365963917331,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
789214477,9/16/2015 11:34:34,1739476343,9/16/2015 11:34:25,false,clixsense,0.9111,21490235,GBR,N7,Woking,86.30.254.232,FLUMAZENIL treats OPIOID OVERDOSE,136,162,,151,172,treats,0.492365963917331,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
789214477,9/16/2015 11:34:57,1739476433,9/16/2015 11:33:55,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,FLUMAZENIL treats OPIOID OVERDOSE,136,162,,151,172,treats,0.492365963917331,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
789214477,9/16/2015 11:45:39,1739479157,9/16/2015 11:45:23,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,no_relation,136,162,,151,172,treats,0.492365963917331,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
789214477,9/16/2015 11:50:46,1739480439,9/16/2015 11:50:28,false,zoombucks,0.7833,4711962,CAN,ON,Markham,174.88.29.138,FLUMAZENIL treats OPIOID OVERDOSE,136,162,,151,172,treats,0.492365963917331,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
789214477,9/16/2015 12:02:56,1739483237,9/16/2015 12:02:28,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,136,162,,151,172,treats,0.492365963917331,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
789214477,9/16/2015 12:12:53,1739485745,9/16/2015 12:12:12,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,no_relation,136,162,,151,172,treats,0.492365963917331,907481,"Clonidine, oxymetazoline, tetrahydozoline, brimonidine, tizanidine; barbiturates; opioids; benzodiazepines  Give naloxone for suspected OPIOID OVERDOSE; consider FLUMAZENIL for benzodiazepine overdose Cholinergic (pinpoint pupils; variable HR; sweaty skin; abdominal cramps and diarrhea)  Organophosphate and carbamate insecticides; chemical warfare nerve agents  Give atropine and pralidoxime; obtain measurements of serum and RBC cholinesterase activity Anticholinergic (agitation; delirium; dilated pupils; tachycardia; decreased peristalsis; dry, flushed skin)  Atropine and related drugs; antihistamines; carbamazepine; phenothiazines; tricyclic antidepressants  Obtain immediate ECG.",OPIOID OVERDOSE,FLUMAZENIL,RO-may_treat
789214478,9/16/2015 12:44:43,1739494027,9/16/2015 12:44:28,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,5 AMINOSALICYLIC ACID treats ULCERATIVE COLITIS,121,95,,138,116,treats,0.995893206467704,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID,TWrex-cause
789214478,9/16/2015 12:46:32,1739494669,9/16/2015 12:46:11,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,5 AMINOSALICYLIC ACID treats ULCERATIVE COLITIS,121,95,,138,116,treats,0.995893206467704,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID,TWrex-cause
789214478,9/16/2015 13:26:23,1739507763,9/16/2015 13:26:00,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,5 AMINOSALICYLIC ACID treats ULCERATIVE COLITIS,121,95,,138,116,treats,0.995893206467704,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID,TWrex-cause
789214478,9/16/2015 13:39:25,1739513778,9/16/2015 13:38:50,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,5 AMINOSALICYLIC ACID treats ULCERATIVE COLITIS,121,95,,138,116,treats,0.995893206467704,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID,TWrex-cause
789214478,9/16/2015 13:53:06,1739517917,9/16/2015 13:52:46,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,5 AMINOSALICYLIC ACID treats ULCERATIVE COLITIS,121,95,,138,116,treats,0.995893206467704,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID,TWrex-cause
789214478,9/16/2015 13:59:03,1739519956,9/16/2015 13:58:15,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,5 AMINOSALICYLIC ACID treats ULCERATIVE COLITIS,121,95,,138,116,treats,0.995893206467704,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID,TWrex-cause
789214478,9/16/2015 14:10:18,1739523924,9/16/2015 14:09:56,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,5 AMINOSALICYLIC ACID treats ULCERATIVE COLITIS,121,95,,138,116,treats,0.995893206467704,803936,"Austin CA, Cann PA, Jones TH et al. Exacerbation of diarrhea and pain in patients treated with 5 AMINOSALICYLIC ACID for ULCERATIVE COLITIS",ULCERATIVE COLITIS,5 AMINOSALICYLIC ACID,TWrex-cause
789214479,9/16/2015 11:31:53,1739475673,9/16/2015 11:31:42,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.970142500145332,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 11:42:33,1739478373,9/16/2015 11:34:57,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.970142500145332,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 11:45:55,1739479201,9/16/2015 11:45:40,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,no_relation,84,166,,95,174,treats,0.970142500145332,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 11:50:56,1739480465,9/16/2015 11:50:47,false,zoombucks,0.7833,4711962,CAN,ON,Markham,174.88.29.138,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.970142500145332,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 12:03:34,1739483448,9/16/2015 12:02:57,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.970142500145332,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 12:14:21,1739486023,9/16/2015 12:13:14,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.970142500145332,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214479,9/16/2015 12:15:54,1739486508,9/16/2015 12:12:54,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,LOSARTAN treats HYPERTENSION,84,166,,95,174,treats,0.970142500145332,804786,"• The LIFE study prospectively randomized >9000 patients 55 to 80 years of age with HYPERTENSION and left ventricular hypertrophy to the angiotensin receptor blocker LOSARTAN or the β blocker atenolol, with additional therapy using a diuretic of a calcium channel blocker as needed to control BP.",HYPERTENSION,LOSARTAN,TWrex-cause
789214480,9/16/2015 11:10:32,1739470484,9/16/2015 11:10:18,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.983869910099907,907626,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
789214480,9/16/2015 11:20:13,1739473229,9/16/2015 11:20:05,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.983869910099907,907626,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
789214480,9/16/2015 11:21:49,1739473587,9/16/2015 11:21:20,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.983869910099907,907626,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
789214480,9/16/2015 11:27:44,1739474719,9/16/2015 11:27:12,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.983869910099907,907626,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
789214480,9/16/2015 11:29:39,1739475186,9/16/2015 11:28:45,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.983869910099907,907626,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
789214480,9/16/2015 11:30:30,1739475388,9/16/2015 11:29:41,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.983869910099907,907626,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
789214480,9/16/2015 11:33:05,1739475965,9/16/2015 11:29:51,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,PROPOFOL treats REFRACTORY STATUS EPILEPTICUS,13,63,,41,71,treats,0.983869910099907,907626,"Treatment of REFRACTORY STATUS EPILEPTICUS with pentobarbital, PROPOFOL or midazolam: a systematic review.",REFRACTORY STATUS EPILEPTICUS,PROPOFOL,RO-may_treat
789214481,9/16/2015 11:05:14,1739469291,9/16/2015 11:05:02,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:10:01,1739470391,9/16/2015 11:09:25,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:19:47,1739473069,9/16/2015 11:19:22,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:20:35,1739473329,9/16/2015 11:20:14,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:26:49,1739474458,9/16/2015 11:26:27,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:27:11,1739474578,9/16/2015 11:26:56,false,elite,0.5833,33798502,USA,DE,"",108.59.8.208,TINEA CAPITIS treats ORAL TERBINAFINE,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214481,9/16/2015 11:27:53,1739474782,9/16/2015 11:26:53,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,ORAL TERBINAFINE treats TINEA CAPITIS,135,53,,147,69,treats,0.994936676326182,803524,"55 ,   61 ,   62 ,   63 ,   65 ,   68 ,   75 ,   77  ORAL TERBINAFINE appears to be as effective as oral griseofulvin for treatment of TINEA CAPITIS caused by  Trichophyton , and requires a shorter duration of treatment which may increase compliance.",TINEA CAPITIS,ORAL TERBINAFINE,TWrex-cause
789214482,9/16/2015 15:00:05,1739542606,9/16/2015 14:59:42,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.737209780774486,906657,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
789214482,9/16/2015 15:08:21,1739545876,9/16/2015 15:06:54,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,HYPERCORTISOLISM treats DEXAMETHASONE,48,104,,64,117,treats,0.737209780774486,906657,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
789214482,9/16/2015 15:13:52,1739548183,9/16/2015 15:12:58,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,no_relation,48,104,,64,117,treats,0.737209780774486,906657,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
789214482,9/16/2015 15:13:54,1739548193,9/16/2015 15:13:30,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.737209780774486,906657,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
789214482,9/16/2015 15:30:44,1739562744,9/16/2015 15:30:36,false,tremorgames,0.5357,24449707,CAN,QC,Laval,96.20.14.148,no_relation,48,104,,64,117,treats,0.737209780774486,906657,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
789214482,9/16/2015 15:34:03,1739565246,9/16/2015 15:33:32,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,no_relation,48,104,,64,117,treats,0.737209780774486,906657,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
789214482,9/16/2015 15:42:36,1739568641,9/16/2015 15:42:13,false,prodege,0.7024,14848125,GBR,V8,Airdrie,86.151.77.161,DEXAMETHASONE treats HYPERCORTISOLISM,48,104,,64,117,treats,0.737209780774486,906657,"Very high plasma androgen levels or evidence of HYPERCORTISOLISM, which is not normally suppressible by DEXAMETHASONE, should lead to the search for a tumor or Cushing's syndrome",HYPERCORTISOLISM,DEXAMETHASONE,RO-may_diagnose
789214483,9/16/2015 17:28:04,1739618264,9/16/2015 17:27:27,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,PARACETAMOL treats MIGRAINE,98,20,,106,31,treats,0.997054485501581,205509,"In combination with [PARACETAMOL] and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including Epidrin and Midrin.",MIGRAINE,PARACETAMOL,TWrex-treat
789214483,9/16/2015 17:38:24,1739624493,9/16/2015 17:38:10,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,PARACETAMOL treats MIGRAINE,98,20,,106,31,treats,0.997054485501581,205509,"In combination with [PARACETAMOL] and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including Epidrin and Midrin.",MIGRAINE,PARACETAMOL,TWrex-treat
789214483,9/16/2015 17:53:25,1739631250,9/16/2015 17:53:04,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,PARACETAMOL treats MIGRAINE,98,20,,106,31,treats,0.997054485501581,205509,"In combination with [PARACETAMOL] and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including Epidrin and Midrin.",MIGRAINE,PARACETAMOL,TWrex-treat
789214483,9/16/2015 17:58:52,1739637293,9/16/2015 17:58:31,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,PARACETAMOL treats MIGRAINE,98,20,,106,31,treats,0.997054485501581,205509,"In combination with [PARACETAMOL] and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including Epidrin and Midrin.",MIGRAINE,PARACETAMOL,TWrex-treat
789214483,9/16/2015 18:13:39,1739658754,9/16/2015 18:13:26,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,PARACETAMOL treats MIGRAINE,98,20,,106,31,treats,0.997054485501581,205509,"In combination with [PARACETAMOL] and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including Epidrin and Midrin.",MIGRAINE,PARACETAMOL,TWrex-treat
789214483,9/16/2015 18:15:15,1739661761,9/16/2015 18:13:32,false,elite,0.875,31883685,GBR,"","",79.66.244.188,PARACETAMOL treats MIGRAINE,98,20,,106,31,treats,0.997054485501581,205509,"In combination with [PARACETAMOL] and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including Epidrin and Midrin.",MIGRAINE,PARACETAMOL,TWrex-treat
789214483,9/16/2015 18:23:04,1739677099,9/16/2015 18:22:32,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,PARACETAMOL treats MIGRAINE,98,20,,106,31,treats,0.997054485501581,205509,"In combination with [PARACETAMOL] and isometheptene, it is the active ingredient of medications for [MIGRAINE] and vascular headaches, including Epidrin and Midrin.",MIGRAINE,PARACETAMOL,TWrex-treat
789214484,9/16/2015 17:54:22,1739632158,9/16/2015 17:53:53,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,SERTRALINE treats PEDIATRIC OCD,96,71,,108,81,treats,1,800316,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE,TWrex-cause
789214484,9/16/2015 17:59:41,1739638267,9/16/2015 17:59:22,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,SERTRALINE treats PEDIATRIC OCD,96,71,,108,81,treats,1,800316,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE,TWrex-cause
789214484,9/16/2015 18:16:11,1739663394,9/16/2015 18:15:52,false,elite,0.875,31883685,GBR,"","",79.66.244.188,SERTRALINE treats PEDIATRIC OCD,96,71,,108,81,treats,1,800316,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE,TWrex-cause
789214484,9/16/2015 18:23:57,1739678883,9/16/2015 18:23:28,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,SERTRALINE treats PEDIATRIC OCD,96,71,,108,81,treats,1,800316,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE,TWrex-cause
789214484,9/16/2015 18:27:44,1739687057,9/16/2015 18:27:22,false,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,SERTRALINE treats PEDIATRIC OCD,96,71,,108,81,treats,1,800316,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE,TWrex-cause
789214484,9/16/2015 18:53:29,1739750507,9/16/2015 18:52:37,false,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,SERTRALINE treats PEDIATRIC OCD,96,71,,108,81,treats,1,800316,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE,TWrex-cause
789214484,9/16/2015 19:06:52,1739773257,9/16/2015 19:06:18,false,neodev,0.704,11026968,CAN,ON,Ottawa,108.168.124.170,SERTRALINE treats PEDIATRIC OCD,96,71,,108,81,treats,1,800316,"Wolkow R, March JS, Safferrman AZ et al. A placebo controlled trial of SERTRALINE treatment for PEDIATRIC OCD",PEDIATRIC OCD,SERTRALINE,TWrex-cause
789214485,9/16/2015 11:31:53,1739475671,9/16/2015 11:31:42,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,INSULIN treats TYPE 2 DIABETES,57,146,,71,153,treats,0.737864787372622,908348,"Insulin resistance is a major risk factor for developing TYPE 2 DIABETES caused by the inability of insulin target tissues to respond properly to INSULIN, and contributes to the morbidity of obesity.",TYPE 2 DIABETES,INSULIN,RO-may_treat
789214485,9/16/2015 11:42:33,1739478375,9/16/2015 11:34:57,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,no_relation,57,146,,71,153,treats,0.737864787372622,908348,"Insulin resistance is a major risk factor for developing TYPE 2 DIABETES caused by the inability of insulin target tissues to respond properly to INSULIN, and contributes to the morbidity of obesity.",TYPE 2 DIABETES,INSULIN,RO-may_treat
789214485,9/16/2015 11:45:55,1739479199,9/16/2015 11:45:40,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,INSULIN treats TYPE 2 DIABETES,57,146,,71,153,treats,0.737864787372622,908348,"Insulin resistance is a major risk factor for developing TYPE 2 DIABETES caused by the inability of insulin target tissues to respond properly to INSULIN, and contributes to the morbidity of obesity.",TYPE 2 DIABETES,INSULIN,RO-may_treat
789214485,9/16/2015 11:50:56,1739480457,9/16/2015 11:50:47,false,zoombucks,0.7833,4711962,CAN,ON,Markham,174.88.29.138,INSULIN treats TYPE 2 DIABETES,57,146,,71,153,treats,0.737864787372622,908348,"Insulin resistance is a major risk factor for developing TYPE 2 DIABETES caused by the inability of insulin target tissues to respond properly to INSULIN, and contributes to the morbidity of obesity.",TYPE 2 DIABETES,INSULIN,RO-may_treat
789214485,9/16/2015 12:03:34,1739483451,9/16/2015 12:02:57,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,INSULIN treats TYPE 2 DIABETES,57,146,,71,153,treats,0.737864787372622,908348,"Insulin resistance is a major risk factor for developing TYPE 2 DIABETES caused by the inability of insulin target tissues to respond properly to INSULIN, and contributes to the morbidity of obesity.",TYPE 2 DIABETES,INSULIN,RO-may_treat
789214485,9/16/2015 12:14:21,1739486025,9/16/2015 12:13:14,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,no_relation,57,146,,71,153,treats,0.737864787372622,908348,"Insulin resistance is a major risk factor for developing TYPE 2 DIABETES caused by the inability of insulin target tissues to respond properly to INSULIN, and contributes to the morbidity of obesity.",TYPE 2 DIABETES,INSULIN,RO-may_treat
789214485,9/16/2015 12:15:54,1739486511,9/16/2015 12:12:54,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,no_relation,57,146,,71,153,treats,0.737864787372622,908348,"Insulin resistance is a major risk factor for developing TYPE 2 DIABETES caused by the inability of insulin target tissues to respond properly to INSULIN, and contributes to the morbidity of obesity.",TYPE 2 DIABETES,INSULIN,RO-may_treat
789214486,9/16/2015 15:14:56,1739548715,9/16/2015 15:14:22,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,ASTHMA treats MONTELUKAST,99,62,,104,73,treats,0.997054485501581,804836,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST,TWrex-cause
789214486,9/16/2015 15:43:15,1739568889,9/16/2015 15:42:59,false,prodege,0.7024,14848125,GBR,V8,Airdrie,86.151.77.161,MONTELUKAST treats ASTHMA,99,62,,104,73,treats,0.997054485501581,804836,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST,TWrex-cause
789214486,9/16/2015 15:49:33,1739571988,9/16/2015 15:49:26,false,instagc,0.7897,33467170,USA,WV,Martinsburg,76.106.109.7,MONTELUKAST treats ASTHMA,99,62,,104,73,treats,0.997054485501581,804836,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST,TWrex-cause
789214486,9/16/2015 15:53:48,1739573887,9/16/2015 15:53:20,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,MONTELUKAST treats ASTHMA,99,62,,104,73,treats,0.997054485501581,804836,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST,TWrex-cause
789214486,9/16/2015 16:02:30,1739578170,9/16/2015 16:02:22,false,bitcoinget,0.8667,21743413,USA,WA,Port Angeles,24.113.29.97,MONTELUKAST treats ASTHMA,99,62,,104,73,treats,0.997054485501581,804836,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST,TWrex-cause
789214486,9/16/2015 16:03:13,1739578603,9/16/2015 16:03:07,false,instagc,0.6012,32352104,USA,ME,Bangor,74.75.63.81,MONTELUKAST treats ASTHMA,99,62,,104,73,treats,0.997054485501581,804836,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST,TWrex-cause
789214486,9/16/2015 16:04:27,1739579212,9/16/2015 16:04:18,false,neodev,0.9167,33155316,GBR,I9,Dereham,31.50.244.140,MONTELUKAST treats ASTHMA,99,62,,104,73,treats,0.997054485501581,804836,One randomized controlled trial (RCT) in children showed that MONTELUKAST plus budesonide improved ASTHMA control better than budesonide alone  (1).,ASTHMA,MONTELUKAST,TWrex-cause
789214487,9/16/2015 10:46:50,1739463637,9/16/2015 10:46:10,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,[COMBINATION THERAPY] treats [COMPLICATED INFLUENZA],16,131,,36,149,treats,0.994936676326182,206856,A 1984 study on [COMPLICATED INFLUENZA] had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for influenza.,[COMPLICATED INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214487,9/16/2015 10:51:29,1739465155,9/16/2015 10:51:17,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,[COMPLICATED INFLUENZA] treats [COMBINATION THERAPY],16,131,,36,149,treats,0.994936676326182,206856,A 1984 study on [COMPLICATED INFLUENZA] had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for influenza.,[COMPLICATED INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214487,9/16/2015 11:04:44,1739469138,9/16/2015 11:04:20,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,[COMBINATION THERAPY] treats [COMPLICATED INFLUENZA],16,131,,36,149,treats,0.994936676326182,206856,A 1984 study on [COMPLICATED INFLUENZA] had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for influenza.,[COMPLICATED INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214487,9/16/2015 11:08:50,1739470198,9/16/2015 11:07:58,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,[COMBINATION THERAPY] treats [COMPLICATED INFLUENZA],16,131,,36,149,treats,0.994936676326182,206856,A 1984 study on [COMPLICATED INFLUENZA] had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for influenza.,[COMPLICATED INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214487,9/16/2015 11:19:03,1739472907,9/16/2015 11:18:27,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,[COMBINATION THERAPY] treats [COMPLICATED INFLUENZA],16,131,,36,149,treats,0.994936676326182,206856,A 1984 study on [COMPLICATED INFLUENZA] had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for influenza.,[COMPLICATED INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214487,9/16/2015 11:19:52,1739473086,9/16/2015 11:19:19,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,[COMBINATION THERAPY] treats [COMPLICATED INFLUENZA],16,131,,36,149,treats,0.994936676326182,206856,A 1984 study on [COMPLICATED INFLUENZA] had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for influenza.,[COMPLICATED INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214487,9/16/2015 11:26:09,1739474370,9/16/2015 11:25:09,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,[COMBINATION THERAPY] treats [COMPLICATED INFLUENZA],16,131,,36,149,treats,0.994936676326182,206856,A 1984 study on [COMPLICATED INFLUENZA] had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for influenza.,[COMPLICATED INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214488,9/16/2015 14:19:23,1739526971,9/16/2015 14:18:30,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,no_relation,67,9,,86,24,treats,0.559016994374947,223212,"However, [INSULIN GLARGINE] was associated with a lower incidence of [SEVERE HYPOGLYCAEMIA] compared with NPH insulin.",[SEVERE HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
789214488,9/16/2015 14:36:53,1739533282,9/16/2015 14:36:15,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,[INSULIN GLARGINE] treats [SEVERE HYPOGLYCAEMIA],67,9,,86,24,treats,0.559016994374947,223212,"However, [INSULIN GLARGINE] was associated with a lower incidence of [SEVERE HYPOGLYCAEMIA] compared with NPH insulin.",[SEVERE HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
789214488,9/16/2015 14:44:50,1739536356,9/16/2015 14:43:56,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,[INSULIN GLARGINE] treats [SEVERE HYPOGLYCAEMIA],67,9,,86,24,treats,0.559016994374947,223212,"However, [INSULIN GLARGINE] was associated with a lower incidence of [SEVERE HYPOGLYCAEMIA] compared with NPH insulin.",[SEVERE HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
789214488,9/16/2015 14:55:22,1739540625,9/16/2015 14:54:54,false,bitcoinget,0.7375,20311164,NLD,09,Utrecht,84.105.54.251,[INSULIN GLARGINE] treats [SEVERE HYPOGLYCAEMIA],67,9,,86,24,treats,0.559016994374947,223212,"However, [INSULIN GLARGINE] was associated with a lower incidence of [SEVERE HYPOGLYCAEMIA] compared with NPH insulin.",[SEVERE HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
789214488,9/16/2015 14:57:52,1739541607,9/16/2015 14:57:23,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,no_relation,67,9,,86,24,treats,0.559016994374947,223212,"However, [INSULIN GLARGINE] was associated with a lower incidence of [SEVERE HYPOGLYCAEMIA] compared with NPH insulin.",[SEVERE HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
789214488,9/16/2015 15:02:37,1739543707,9/16/2015 15:00:14,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,[INSULIN GLARGINE] treats [SEVERE HYPOGLYCAEMIA],67,9,,86,24,treats,0.559016994374947,223212,"However, [INSULIN GLARGINE] was associated with a lower incidence of [SEVERE HYPOGLYCAEMIA] compared with NPH insulin.",[SEVERE HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
789214488,9/16/2015 15:09:11,1739546233,9/16/2015 15:08:22,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,no_relation,67,9,,86,24,treats,0.559016994374947,223212,"However, [INSULIN GLARGINE] was associated with a lower incidence of [SEVERE HYPOGLYCAEMIA] compared with NPH insulin.",[SEVERE HYPOGLYCAEMIA],[INSULIN GLARGINE],TWrex-treat
789214489,9/16/2015 14:19:23,1739526973,9/16/2015 14:18:30,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,METRONIDAZOLE treats MYOSITIS,84,48,,92,61,treats,0.943456353,206397,"Agents that have been used include albendazole, [METRONIDAZOLE] and cotrimoxazole for [MYOSITIS].",MYOSITIS,METRONIDAZOLE,TWrex-treat
789214489,9/16/2015 14:36:53,1739533283,9/16/2015 14:36:15,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,METRONIDAZOLE treats MYOSITIS,84,48,,92,61,treats,0.943456353,206397,"Agents that have been used include albendazole, [METRONIDAZOLE] and cotrimoxazole for [MYOSITIS].",MYOSITIS,METRONIDAZOLE,TWrex-treat
789214489,9/16/2015 14:44:50,1739536355,9/16/2015 14:43:56,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,METRONIDAZOLE treats MYOSITIS,84,48,,92,61,treats,0.943456353,206397,"Agents that have been used include albendazole, [METRONIDAZOLE] and cotrimoxazole for [MYOSITIS].",MYOSITIS,METRONIDAZOLE,TWrex-treat
789214489,9/16/2015 14:55:22,1739540623,9/16/2015 14:54:54,false,bitcoinget,0.7375,20311164,NLD,09,Utrecht,84.105.54.251,METRONIDAZOLE treats MYOSITIS,84,48,,92,61,treats,0.943456353,206397,"Agents that have been used include albendazole, [METRONIDAZOLE] and cotrimoxazole for [MYOSITIS].",MYOSITIS,METRONIDAZOLE,TWrex-treat
789214489,9/16/2015 14:57:52,1739541601,9/16/2015 14:57:23,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,METRONIDAZOLE treats MYOSITIS,84,48,,92,61,treats,0.943456353,206397,"Agents that have been used include albendazole, [METRONIDAZOLE] and cotrimoxazole for [MYOSITIS].",MYOSITIS,METRONIDAZOLE,TWrex-treat
789214489,9/16/2015 15:02:37,1739543695,9/16/2015 15:00:14,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,METRONIDAZOLE treats MYOSITIS,84,48,,92,61,treats,0.943456353,206397,"Agents that have been used include albendazole, [METRONIDAZOLE] and cotrimoxazole for [MYOSITIS].",MYOSITIS,METRONIDAZOLE,TWrex-treat
789214489,9/16/2015 15:09:11,1739546204,9/16/2015 15:08:22,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,METRONIDAZOLE treats MYOSITIS,84,48,,92,61,treats,0.943456353,206397,"Agents that have been used include albendazole, [METRONIDAZOLE] and cotrimoxazole for [MYOSITIS].",MYOSITIS,METRONIDAZOLE,TWrex-treat
789214490,9/16/2015 15:56:03,1739574982,9/16/2015 15:55:40,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949588,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 16:16:36,1739584330,9/16/2015 16:16:19,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949588,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 16:39:27,1739594441,9/16/2015 16:39:17,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949588,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 16:52:25,1739600737,9/16/2015 16:52:19,false,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949588,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 17:25:13,1739616361,9/16/2015 17:24:24,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949588,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 17:28:45,1739618771,9/16/2015 17:27:35,false,neodev,1.0,23017572,USA,CA,Santa Ana,67.215.241.18,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949588,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214490,9/16/2015 17:37:06,1739623941,9/16/2015 17:36:42,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,ALPROX treats ERECTILE DYSFUNCTION,70,48,,90,54,treats,0.9704949588,207310,NexMed is developing transdermal formulations - [ALPROX]-TDfor men with [ERECTILE DYSFUNCTION] and Femproxfor female sexual arousal disorder.,ERECTILE DYSFUNCTION,ALPROX,TWrex-treat
789214491,9/16/2015 12:45:05,1739494178,9/16/2015 12:44:44,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,[DOSE TRIAL OF TAPENTADOL 25MG 200MG] treats [POST SURGERY DENTAL PAIN],109,18,,133,53,treats,0.979957887012223,211605,A phase II single [DOSE TRIAL OF TAPENTADOL 25MG 200MG] ibuprofen 400mg and morphine IR 60mg was evaluated in [POST SURGERY DENTAL PAIN],[POST SURGERY DENTAL PAIN],[DOSE TRIAL OF TAPENTADOL 25MG 200MG],TWrex-treat
789214491,9/16/2015 12:46:48,1739494854,9/16/2015 12:46:33,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,[DOSE TRIAL OF TAPENTADOL 25MG 200MG] treats [POST SURGERY DENTAL PAIN],109,18,,133,53,treats,0.979957887012223,211605,A phase II single [DOSE TRIAL OF TAPENTADOL 25MG 200MG] ibuprofen 400mg and morphine IR 60mg was evaluated in [POST SURGERY DENTAL PAIN],[POST SURGERY DENTAL PAIN],[DOSE TRIAL OF TAPENTADOL 25MG 200MG],TWrex-treat
789214491,9/16/2015 13:28:10,1739508243,9/16/2015 13:26:25,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,no_relation,109,18,,133,53,treats,0.979957887012223,211605,A phase II single [DOSE TRIAL OF TAPENTADOL 25MG 200MG] ibuprofen 400mg and morphine IR 60mg was evaluated in [POST SURGERY DENTAL PAIN],[POST SURGERY DENTAL PAIN],[DOSE TRIAL OF TAPENTADOL 25MG 200MG],TWrex-treat
789214491,9/16/2015 13:40:57,1739514225,9/16/2015 13:39:26,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,[DOSE TRIAL OF TAPENTADOL 25MG 200MG] treats [POST SURGERY DENTAL PAIN],109,18,,133,53,treats,0.979957887012223,211605,A phase II single [DOSE TRIAL OF TAPENTADOL 25MG 200MG] ibuprofen 400mg and morphine IR 60mg was evaluated in [POST SURGERY DENTAL PAIN],[POST SURGERY DENTAL PAIN],[DOSE TRIAL OF TAPENTADOL 25MG 200MG],TWrex-treat
789214491,9/16/2015 13:53:23,1739518031,9/16/2015 13:53:07,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,[DOSE TRIAL OF TAPENTADOL 25MG 200MG] treats [POST SURGERY DENTAL PAIN],109,18,,133,53,treats,0.979957887012223,211605,A phase II single [DOSE TRIAL OF TAPENTADOL 25MG 200MG] ibuprofen 400mg and morphine IR 60mg was evaluated in [POST SURGERY DENTAL PAIN],[POST SURGERY DENTAL PAIN],[DOSE TRIAL OF TAPENTADOL 25MG 200MG],TWrex-treat
789214491,9/16/2015 14:00:12,1739520345,9/16/2015 13:59:39,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,[DOSE TRIAL OF TAPENTADOL 25MG 200MG] treats [POST SURGERY DENTAL PAIN],109,18,,133,53,treats,0.979957887012223,211605,A phase II single [DOSE TRIAL OF TAPENTADOL 25MG 200MG] ibuprofen 400mg and morphine IR 60mg was evaluated in [POST SURGERY DENTAL PAIN],[POST SURGERY DENTAL PAIN],[DOSE TRIAL OF TAPENTADOL 25MG 200MG],TWrex-treat
789214491,9/16/2015 14:11:16,1739524227,9/16/2015 14:10:19,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,[DOSE TRIAL OF TAPENTADOL 25MG 200MG] treats [POST SURGERY DENTAL PAIN],109,18,,133,53,treats,0.979957887012223,211605,A phase II single [DOSE TRIAL OF TAPENTADOL 25MG 200MG] ibuprofen 400mg and morphine IR 60mg was evaluated in [POST SURGERY DENTAL PAIN],[POST SURGERY DENTAL PAIN],[DOSE TRIAL OF TAPENTADOL 25MG 200MG],TWrex-treat
789214492,9/16/2015 09:38:17,1739443707,9/16/2015 09:37:29,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.997054485501581,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 09:44:40,1739445216,9/16/2015 09:44:27,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.997054485501581,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 09:51:53,1739446974,9/16/2015 09:50:51,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.997054485501581,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 09:54:06,1739447676,9/16/2015 09:53:52,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.997054485501581,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 09:54:08,1739447687,9/16/2015 09:53:45,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.997054485501581,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 10:05:59,1739451523,9/16/2015 10:04:57,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.997054485501581,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214492,9/16/2015 10:11:51,1739453271,9/16/2015 10:11:29,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,AMPHOTERICIN B treats PRESUMPTIVE BLASTOMYCOSIS,272,43,,296,57,treats,0.997054485501581,800204,"36 ,   49 ,   50 ,   51 ,   52 ,   436  IV AMPHOTERICIN B is preferred for initial treatment of severe blastomycosis, especially infections involving the CNS  51 ,   52 ,   55 ,   56 ,   50 ,   51 ,   52 ,   53 ,   54 ,   61 ,   424 ,   436   and for initial treatment of PRESUMPTIVE BLASTOMYCOSIS in immunocompromised patients, including HIV infected individuals.",PRESUMPTIVE BLASTOMYCOSIS,AMPHOTERICIN B,TWrex-cause
789214493,9/16/2015 12:45:20,1739494277,9/16/2015 12:45:06,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,ORAL CYCLOPHOSPHAMIDE treats GENERALIZED WEGENER'S GRANULOMATOSIS,229,187,,264,208,treats,0.971665620577517,800435,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE,TWrex-cause
789214493,9/16/2015 12:47:14,1739495019,9/16/2015 12:46:49,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,ORAL CYCLOPHOSPHAMIDE treats GENERALIZED WEGENER'S GRANULOMATOSIS,229,187,,264,208,treats,0.971665620577517,800435,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE,TWrex-cause
789214493,9/16/2015 13:29:25,1739508499,9/16/2015 13:28:11,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,ORAL CYCLOPHOSPHAMIDE treats GENERALIZED WEGENER'S GRANULOMATOSIS,229,187,,264,208,treats,0.971665620577517,800435,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE,TWrex-cause
789214493,9/16/2015 13:41:49,1739514438,9/16/2015 13:40:59,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,ORAL CYCLOPHOSPHAMIDE treats GENERALIZED WEGENER'S GRANULOMATOSIS,229,187,,264,208,treats,0.971665620577517,800435,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE,TWrex-cause
789214493,9/16/2015 13:53:49,1739518211,9/16/2015 13:53:24,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,ORAL CYCLOPHOSPHAMIDE treats GENERALIZED WEGENER'S GRANULOMATOSIS,229,187,,264,208,treats,0.971665620577517,800435,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE,TWrex-cause
789214493,9/16/2015 14:01:12,1739520659,9/16/2015 14:00:13,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,ORAL CYCLOPHOSPHAMIDE treats GENERALIZED WEGENER'S GRANULOMATOSIS,229,187,,264,208,treats,0.971665620577517,800435,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE,TWrex-cause
789214493,9/16/2015 14:20:16,1739527370,9/16/2015 14:11:17,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,GENERALIZED WEGENER'S GRANULOMATOSIS treats ORAL CYCLOPHOSPHAMIDE,229,187,,264,208,treats,0.971665620577517,800435,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE,TWrex-cause
789214494,9/16/2015 12:18:52,1739487153,9/16/2015 12:18:37,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,HEPARIN treats MYOCARDIAL INFARCTION,70,172,,90,179,treats,0.949425326555083,908250,A meta analysis of these two studies showed that the risk of death or MYOCARDIAL INFARCTION was consistently approximately 20% lower in enoxaparin treated patients than in HEPARIN treated patients.,MYOCARDIAL INFARCTION,HEPARIN,RO-may_treat
789214494,9/16/2015 12:44:26,1739493954,9/16/2015 12:43:53,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,HEPARIN treats MYOCARDIAL INFARCTION,70,172,,90,179,treats,0.949425326555083,908250,A meta analysis of these two studies showed that the risk of death or MYOCARDIAL INFARCTION was consistently approximately 20% lower in enoxaparin treated patients than in HEPARIN treated patients.,MYOCARDIAL INFARCTION,HEPARIN,RO-may_treat
789214494,9/16/2015 12:46:10,1739494544,9/16/2015 12:45:46,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,HEPARIN treats MYOCARDIAL INFARCTION,70,172,,90,179,treats,0.949425326555083,908250,A meta analysis of these two studies showed that the risk of death or MYOCARDIAL INFARCTION was consistently approximately 20% lower in enoxaparin treated patients than in HEPARIN treated patients.,MYOCARDIAL INFARCTION,HEPARIN,RO-may_treat
789214494,9/16/2015 13:25:59,1739507637,9/16/2015 13:22:18,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,no_relation,70,172,,90,179,treats,0.949425326555083,908250,A meta analysis of these two studies showed that the risk of death or MYOCARDIAL INFARCTION was consistently approximately 20% lower in enoxaparin treated patients than in HEPARIN treated patients.,MYOCARDIAL INFARCTION,HEPARIN,RO-may_treat
789214494,9/16/2015 13:38:48,1739513535,9/16/2015 13:38:02,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,70,172,,90,179,treats,0.949425326555083,908250,A meta analysis of these two studies showed that the risk of death or MYOCARDIAL INFARCTION was consistently approximately 20% lower in enoxaparin treated patients than in HEPARIN treated patients.,MYOCARDIAL INFARCTION,HEPARIN,RO-may_treat
789214494,9/16/2015 13:52:46,1739517822,9/16/2015 13:52:27,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,HEPARIN treats MYOCARDIAL INFARCTION,70,172,,90,179,treats,0.949425326555083,908250,A meta analysis of these two studies showed that the risk of death or MYOCARDIAL INFARCTION was consistently approximately 20% lower in enoxaparin treated patients than in HEPARIN treated patients.,MYOCARDIAL INFARCTION,HEPARIN,RO-may_treat
789214494,9/16/2015 13:59:39,1739520151,9/16/2015 13:59:03,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,HEPARIN treats MYOCARDIAL INFARCTION,70,172,,90,179,treats,0.949425326555083,908250,A meta analysis of these two studies showed that the risk of death or MYOCARDIAL INFARCTION was consistently approximately 20% lower in enoxaparin treated patients than in HEPARIN treated patients.,MYOCARDIAL INFARCTION,HEPARIN,RO-may_treat
789214495,9/16/2015 14:48:23,1739537725,9/16/2015 14:48:06,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 14:59:41,1739542391,9/16/2015 14:59:25,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:06:52,1739545288,9/16/2015 15:05:18,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:12:56,1739547781,9/16/2015 15:11:52,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,no_relation,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:13:28,1739547997,9/16/2015 15:13:02,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:14:42,1739548538,9/16/2015 15:13:50,false,clixsense,0.3143,6336109,CAN,BC,Prince George,198.254.211.52,no_relation,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214495,9/16/2015 15:30:35,1739562609,9/16/2015 15:30:14,false,tremorgames,0.5357,24449707,CAN,QC,Laval,96.20.14.148,LORAZEPAM treats EMESIS,170,139,,175,148,treats,0.99654575824488,804523,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM,TWrex-cause
789214496,9/16/2015 11:43:11,1739478559,9/16/2015 11:42:46,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,INTERLEUKIN 2 PLUS INTERFERON ALPHA treats RENAL CELL CARCINOMA,118,79,,137,114,treats,0.696310623822791,800082,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA,TWrex-cause
789214496,9/16/2015 11:47:39,1739479693,9/16/2015 11:46:12,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,no_relation,118,79,,137,114,treats,0.696310623822791,800082,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA,TWrex-cause
789214496,9/16/2015 12:04:09,1739483573,9/16/2015 12:03:51,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,INTERLEUKIN 2 PLUS INTERFERON ALPHA treats RENAL CELL CARCINOMA,118,79,,137,114,treats,0.696310623822791,800082,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA,TWrex-cause
789214496,9/16/2015 12:16:02,1739486531,9/16/2015 12:14:52,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,no_relation,118,79,,137,114,treats,0.696310623822791,800082,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA,TWrex-cause
789214496,9/16/2015 12:16:25,1739486611,9/16/2015 12:16:13,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,INTERLEUKIN 2 PLUS INTERFERON ALPHA treats RENAL CELL CARCINOMA,118,79,,137,114,treats,0.696310623822791,800082,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA,TWrex-cause
789214496,9/16/2015 12:30:01,1739489641,9/16/2015 12:29:50,false,instagc,0.8397,13581319,USA,IL,Trenton,208.70.36.12,INTERLEUKIN 2 PLUS INTERFERON ALPHA treats RENAL CELL CARCINOMA,118,79,,137,114,treats,0.696310623822791,800082,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA,TWrex-cause
789214496,9/16/2015 12:53:36,1739496949,9/16/2015 12:53:26,false,instagc,0.8661,15577915,USA,IL,Trenton,208.70.36.12,INTERLEUKIN 2 PLUS INTERFERON ALPHA treats RENAL CELL CARCINOMA,118,79,,137,114,treats,0.696310623822791,800082,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA,TWrex-cause
789214497,9/16/2015 12:18:52,1739487154,9/16/2015 12:18:37,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,WARFARIN treats STROKE,82,125,,87,133,treats,0.961523947640823,804645,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN,TWrex-cause
789214497,9/16/2015 12:44:26,1739493953,9/16/2015 12:43:53,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,WARFARIN treats STROKE,82,125,,87,133,treats,0.961523947640823,804645,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN,TWrex-cause
789214497,9/16/2015 12:46:10,1739494547,9/16/2015 12:45:46,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,WARFARIN treats STROKE,82,125,,87,133,treats,0.961523947640823,804645,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN,TWrex-cause
789214497,9/16/2015 13:25:59,1739507632,9/16/2015 13:22:18,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,no_relation,82,125,,87,133,treats,0.961523947640823,804645,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN,TWrex-cause
789214497,9/16/2015 13:38:48,1739513534,9/16/2015 13:38:02,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,WARFARIN treats STROKE,82,125,,87,133,treats,0.961523947640823,804645,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN,TWrex-cause
789214497,9/16/2015 13:52:46,1739517821,9/16/2015 13:52:27,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,WARFARIN treats STROKE,82,125,,87,133,treats,0.961523947640823,804645,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN,TWrex-cause
789214497,9/16/2015 13:59:39,1739520154,9/16/2015 13:59:03,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,WARFARIN treats STROKE,82,125,,87,133,treats,0.961523947640823,804645,"January 2010   Volume 152, Number 1  Therapeutics  Higher dose dabigatran reduced STROKE but not major hemorrhage, more than WARFARIN in atrial fibrillation.",STROKE,WARFARIN,TWrex-cause
789214498,9/16/2015 12:44:43,1739494028,9/16/2015 12:44:28,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 12:46:32,1739494668,9/16/2015 12:46:11,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 13:26:23,1739507762,9/16/2015 13:26:00,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 13:39:25,1739513776,9/16/2015 13:38:50,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 13:53:06,1739517916,9/16/2015 13:52:46,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,MAGNESIUM SULPHATE treats PRE ECLAMPSIA,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 13:59:03,1739519953,9/16/2015 13:58:15,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,no_relation,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214498,9/16/2015 14:10:18,1739523925,9/16/2015 14:09:56,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,no_relation,95,59,,107,77,treats,0.948683298050514,804676,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE,TWrex-cause
789214499,9/16/2015 09:37:28,1739443458,9/16/2015 09:36:15,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,FOSCARNET treats CMV INFECTIONS,212,257,,225,266,treats,0.98058067569092,804400,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET,TWrex-cause
789214499,9/16/2015 09:44:26,1739445174,9/16/2015 09:44:11,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,FOSCARNET treats CMV INFECTIONS,212,257,,225,266,treats,0.98058067569092,804400,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET,TWrex-cause
789214499,9/16/2015 09:50:50,1739446707,9/16/2015 09:50:24,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,FOSCARNET treats CMV INFECTIONS,212,257,,225,266,treats,0.98058067569092,804400,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET,TWrex-cause
789214499,9/16/2015 09:53:45,1739447574,9/16/2015 09:53:17,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,FOSCARNET treats CMV INFECTIONS,212,257,,225,266,treats,0.98058067569092,804400,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET,TWrex-cause
789214499,9/16/2015 09:53:51,1739447597,9/16/2015 09:53:35,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,212,257,,225,266,treats,0.98058067569092,804400,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET,TWrex-cause
789214499,9/16/2015 10:04:16,1739450860,9/16/2015 10:04:10,false,clixsense,0.4905,19162475,GBR,P8,Trowbridge,82.33.126.30,FOSCARNET treats CMV INFECTIONS,212,257,,225,266,treats,0.98058067569092,804400,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET,TWrex-cause
789214499,9/16/2015 10:04:56,1739451166,9/16/2015 10:03:58,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,no_relation,212,257,,225,266,treats,0.98058067569092,804400,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET,TWrex-cause
789214500,9/16/2015 10:13:41,1739453729,9/16/2015 10:13:30,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,ACETAMINOPHEN treats MIGRAINE HEADACHE PAIN,112,61,,133,74,treats,0.990147542976674,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of ACETAMINOPHEN aspirin, and caffeine in alleviating MIGRAINE HEADACHE PAIN",MIGRAINE HEADACHE PAIN,ACETAMINOPHEN,RO-may_treat
789214500,9/16/2015 10:14:25,1739454012,9/16/2015 10:13:57,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,ACETAMINOPHEN treats MIGRAINE HEADACHE PAIN,112,61,,133,74,treats,0.990147542976674,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of ACETAMINOPHEN aspirin, and caffeine in alleviating MIGRAINE HEADACHE PAIN",MIGRAINE HEADACHE PAIN,ACETAMINOPHEN,RO-may_treat
789214500,9/16/2015 10:15:18,1739454325,9/16/2015 10:14:47,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,ACETAMINOPHEN treats MIGRAINE HEADACHE PAIN,112,61,,133,74,treats,0.990147542976674,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of ACETAMINOPHEN aspirin, and caffeine in alleviating MIGRAINE HEADACHE PAIN",MIGRAINE HEADACHE PAIN,ACETAMINOPHEN,RO-may_treat
789214500,9/16/2015 10:42:07,1739462308,9/16/2015 10:41:40,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,ACETAMINOPHEN treats MIGRAINE HEADACHE PAIN,112,61,,133,74,treats,0.990147542976674,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of ACETAMINOPHEN aspirin, and caffeine in alleviating MIGRAINE HEADACHE PAIN",MIGRAINE HEADACHE PAIN,ACETAMINOPHEN,RO-may_treat
789214500,9/16/2015 10:43:42,1739462665,9/16/2015 10:43:15,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,ACETAMINOPHEN treats MIGRAINE HEADACHE PAIN,112,61,,133,74,treats,0.990147542976674,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of ACETAMINOPHEN aspirin, and caffeine in alleviating MIGRAINE HEADACHE PAIN",MIGRAINE HEADACHE PAIN,ACETAMINOPHEN,RO-may_treat
789214500,9/16/2015 10:45:53,1739463333,9/16/2015 10:44:43,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,MIGRAINE HEADACHE PAIN treats ACETAMINOPHEN,112,61,,133,74,treats,0.990147542976674,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of ACETAMINOPHEN aspirin, and caffeine in alleviating MIGRAINE HEADACHE PAIN",MIGRAINE HEADACHE PAIN,ACETAMINOPHEN,RO-may_treat
789214500,9/16/2015 11:00:29,1739467834,9/16/2015 11:00:15,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,no_relation,112,61,,133,74,treats,0.990147542976674,907500,"Lipton RB, Stewart WF, Ryan RE et al. Efficacy and safety of ACETAMINOPHEN aspirin, and caffeine in alleviating MIGRAINE HEADACHE PAIN",MIGRAINE HEADACHE PAIN,ACETAMINOPHEN,RO-may_treat
789214501,9/16/2015 11:29:34,1739475159,9/16/2015 11:28:37,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,no_relation,82,103,,85,116,treats,0.369800130816819,813518,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS,TWrex-cause
789214501,9/16/2015 11:31:19,1739475575,9/16/2015 11:30:47,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,no_relation,82,103,,85,116,treats,0.369800130816819,813518,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS,TWrex-cause
789214501,9/16/2015 11:31:36,1739475621,9/16/2015 11:30:38,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,no_relation,82,103,,85,116,treats,0.369800130816819,813518,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS,TWrex-cause
789214501,9/16/2015 11:33:55,1739476142,9/16/2015 11:33:38,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,ENDOMETRIOSIS treats PAIN,82,103,,85,116,treats,0.369800130816819,813518,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS,TWrex-cause
789214501,9/16/2015 11:34:24,1739476331,9/16/2015 11:33:43,false,clixsense,0.9111,21490235,GBR,N7,Woking,86.30.254.232,no_relation,82,103,,85,116,treats,0.369800130816819,813518,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS,TWrex-cause
789214501,9/16/2015 11:45:22,1739479083,9/16/2015 11:45:06,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,no_relation,82,103,,85,116,treats,0.369800130816819,813518,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS,TWrex-cause
789214501,9/16/2015 11:48:09,1739479829,9/16/2015 11:40:39,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,82,103,,85,116,treats,0.369800130816819,813518,Evidence: • Four studies reported on evidence suggesting that the LNG IUS reduces PAIN associated with ENDOMETRIOSIS which may last up to 3 years ( 48 ;  49 ;  50 ;  51.,PAIN,ENDOMETRIOSIS,TWrex-cause
789214502,9/16/2015 09:43:01,1739444912,9/16/2015 09:41:52,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.993127066322842,908204,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
789214502,9/16/2015 09:45:11,1739445354,9/16/2015 09:45:00,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.993127066322842,908204,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
789214502,9/16/2015 09:52:56,1739447345,9/16/2015 09:52:24,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.993127066322842,908204,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
789214502,9/16/2015 09:54:45,1739447881,9/16/2015 09:54:26,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.993127066322842,908204,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
789214502,9/16/2015 09:55:01,1739447964,9/16/2015 09:54:34,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.993127066322842,908204,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
789214502,9/16/2015 10:08:39,1739452386,9/16/2015 10:07:42,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,no_relation,227,276,,242,285,treats,0.993127066322842,908204,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
789214502,9/16/2015 10:13:23,1739453677,9/16/2015 10:12:33,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,MELPHALAN treats MULTIPLE MYELOMA,227,276,,242,285,treats,0.993127066322842,908204,"The highest MCV and MCV increases during therapy among 203 patients were observed in those cancers and cytotoxic therapies most commonly followed by secondary leukemia: Hodgkin's disease treated with MOPP and radiotherapy, and MULTIPLE MYELOMA and ovarian cancer treated with MELPHALAN",MULTIPLE MYELOMA,MELPHALAN,RO-may_treat
789214503,9/16/2015 10:13:30,1739453693,9/16/2015 10:13:10,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:13:56,1739453805,9/16/2015 10:13:24,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:14:46,1739454125,9/16/2015 10:13:30,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:20:27,1739456000,9/16/2015 10:19:41,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:35:40,1739460491,9/16/2015 10:33:49,false,gifthunterclub,0.7,30884086,AUS,04,"",118.208.145.92,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 10:41:38,1739462146,9/16/2015 10:40:45,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,no_relation,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214503,9/16/2015 11:00:15,1739467756,9/16/2015 10:59:46,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,AND B VIRUS INFECTIONS treats A OR B VIRUS IN ADULTS,35,101,,56,123,treats,0.583459965991578,811389,"Prevention of Seasonal Influenza A AND B VIRUS INFECTIONS  Prevention of illness caused by influenza A OR B VIRUS IN ADULTS adolescents, and children ≥1 year of age.",AND B VIRUS INFECTIONS,A OR B VIRUS IN ADULTS,TWrex-cause
789214504,9/16/2015 16:18:42,1739585318,9/16/2015 16:18:26,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,ENOXACIN treats ACUTE UNCOMPLICATED URETHRA GONORRHEA,153,111,,189,119,treats,1,803437,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN,TWrex-cause
789214504,9/16/2015 16:39:50,1739594598,9/16/2015 16:39:40,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,ENOXACIN treats ACUTE UNCOMPLICATED URETHRA GONORRHEA,153,111,,189,119,treats,1,803437,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN,TWrex-cause
789214504,9/16/2015 17:26:31,1739617199,9/16/2015 17:26:09,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,ENOXACIN treats ACUTE UNCOMPLICATED URETHRA GONORRHEA,153,111,,189,119,treats,1,803437,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN,TWrex-cause
789214504,9/16/2015 17:37:43,1739624188,9/16/2015 17:37:23,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,ENOXACIN treats ACUTE UNCOMPLICATED URETHRA GONORRHEA,153,111,,189,119,treats,1,803437,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN,TWrex-cause
789214504,9/16/2015 17:52:36,1739630504,9/16/2015 17:51:51,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,ENOXACIN treats ACUTE UNCOMPLICATED URETHRA GONORRHEA,153,111,,189,119,treats,1,803437,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN,TWrex-cause
789214504,9/16/2015 17:53:01,1739630859,9/16/2015 17:52:53,false,prodege,0.881,3587109,CAN,NS,Havre Boucher,142.166.204.244,ENOXACIN treats ACUTE UNCOMPLICATED URETHRA GONORRHEA,153,111,,189,119,treats,1,803437,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN,TWrex-cause
789214504,9/16/2015 17:58:07,1739636368,9/16/2015 17:57:24,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,ENOXACIN treats ACUTE UNCOMPLICATED URETHRA GONORRHEA,153,111,,189,119,treats,1,803437,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN,TWrex-cause
789214505,9/16/2015 14:21:05,1739527633,9/16/2015 14:20:30,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,INSULIN GLARGINE treats TYPE 1 DIABETES,150,118,,164,134,treats,0.821994936526786,800424,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
789214505,9/16/2015 14:48:05,1739537585,9/16/2015 14:47:48,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,INSULIN GLARGINE treats TYPE 1 DIABETES,150,118,,164,134,treats,0.821994936526786,800424,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
789214505,9/16/2015 14:59:24,1739542278,9/16/2015 14:58:46,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,INSULIN GLARGINE treats TYPE 1 DIABETES,150,118,,164,134,treats,0.821994936526786,800424,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
789214505,9/16/2015 15:05:08,1739544673,9/16/2015 15:04:01,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,INSULIN GLARGINE treats TYPE 1 DIABETES,150,118,,164,134,treats,0.821994936526786,800424,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
789214505,9/16/2015 15:11:51,1739547372,9/16/2015 15:10:40,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,TYPE 1 DIABETES treats INSULIN GLARGINE,150,118,,164,134,treats,0.821994936526786,800424,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
789214505,9/16/2015 15:12:59,1739547804,9/16/2015 15:12:22,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,TYPE 1 DIABETES treats INSULIN GLARGINE,150,118,,164,134,treats,0.821994936526786,800424,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
789214505,9/16/2015 15:13:47,1739548162,9/16/2015 15:13:04,false,clixsense,0.3143,6336109,CAN,BC,Prince George,198.254.211.52,INSULIN GLARGINE treats TYPE 1 DIABETES,150,118,,164,134,treats,0.821994936526786,800424,"Heise T, Nosek L, Ronn BB et al. Lower within subject variability of insulin detemir in comparison to NPH insulin and INSULIN GLARGINE in people with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN GLARGINE,TWrex-cause
789214506,9/16/2015 12:04:59,1739483811,9/16/2015 12:04:31,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,no_relation,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 12:18:37,1739487109,9/16/2015 12:18:02,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,FONDAPARINUX VERSUS POSTOPERATIVE treats VENOUS THROMBOEMBOLISM,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 12:43:52,1739493800,9/16/2015 12:43:25,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,FONDAPARINUX VERSUS POSTOPERATIVE treats VENOUS THROMBOEMBOLISM,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 12:45:46,1739494383,9/16/2015 12:45:26,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,FONDAPARINUX VERSUS POSTOPERATIVE treats VENOUS THROMBOEMBOLISM,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 12:53:47,1739497030,9/16/2015 12:53:38,false,instagc,0.8661,15577915,USA,IL,Trenton,208.70.36.12,FONDAPARINUX VERSUS POSTOPERATIVE treats VENOUS THROMBOEMBOLISM,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 13:22:17,1739506456,9/16/2015 13:20:43,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,no_relation,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214506,9/16/2015 13:38:00,1739513090,9/16/2015 13:37:22,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,126,63,,147,96,treats,0.986393923832144,804378,"1]  Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.",VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE,TWrex-cause
789214507,9/16/2015 15:14:19,1739548431,9/16/2015 15:13:56,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,PITAVASTATIN treats HYPERCHOLESTEROLAEMIA,54,24,,75,36,treats,0.9958932065,206484,"Like the other statins, [PITAVASTATIN] is indicated for [HYPERCHOLESTEROLAEMIA] and for the prevention of cardiovascular disease.",HYPERCHOLESTEROLAEMIA,PITAVASTATIN,TWrex-treat
789214507,9/16/2015 15:15:20,1739548844,9/16/2015 15:13:53,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,PITAVASTATIN treats HYPERCHOLESTEROLAEMIA,54,24,,75,36,treats,0.9958932065,206484,"Like the other statins, [PITAVASTATIN] is indicated for [HYPERCHOLESTEROLAEMIA] and for the prevention of cardiovascular disease.",HYPERCHOLESTEROLAEMIA,PITAVASTATIN,TWrex-treat
789214507,9/16/2015 15:42:57,1739568793,9/16/2015 15:42:38,false,prodege,0.7024,14848125,GBR,V8,Airdrie,86.151.77.161,PITAVASTATIN treats HYPERCHOLESTEROLAEMIA,54,24,,75,36,treats,0.9958932065,206484,"Like the other statins, [PITAVASTATIN] is indicated for [HYPERCHOLESTEROLAEMIA] and for the prevention of cardiovascular disease.",HYPERCHOLESTEROLAEMIA,PITAVASTATIN,TWrex-treat
789214507,9/16/2015 15:49:10,1739571865,9/16/2015 15:45:15,false,instagc,0.7897,33467170,USA,WV,Martinsburg,76.106.109.7,PITAVASTATIN treats HYPERCHOLESTEROLAEMIA,54,24,,75,36,treats,0.9958932065,206484,"Like the other statins, [PITAVASTATIN] is indicated for [HYPERCHOLESTEROLAEMIA] and for the prevention of cardiovascular disease.",HYPERCHOLESTEROLAEMIA,PITAVASTATIN,TWrex-treat
789214507,9/16/2015 15:53:19,1739573707,9/16/2015 15:52:54,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,PITAVASTATIN treats HYPERCHOLESTEROLAEMIA,54,24,,75,36,treats,0.9958932065,206484,"Like the other statins, [PITAVASTATIN] is indicated for [HYPERCHOLESTEROLAEMIA] and for the prevention of cardiovascular disease.",HYPERCHOLESTEROLAEMIA,PITAVASTATIN,TWrex-treat
789214507,9/16/2015 16:02:20,1739578063,9/16/2015 16:02:05,false,bitcoinget,0.8667,21743413,USA,WA,Port Angeles,24.113.29.97,PITAVASTATIN treats HYPERCHOLESTEROLAEMIA,54,24,,75,36,treats,0.9958932065,206484,"Like the other statins, [PITAVASTATIN] is indicated for [HYPERCHOLESTEROLAEMIA] and for the prevention of cardiovascular disease.",HYPERCHOLESTEROLAEMIA,PITAVASTATIN,TWrex-treat
789214507,9/16/2015 16:03:07,1739578518,9/16/2015 16:02:46,false,instagc,0.6012,32352104,USA,ME,Bangor,74.75.63.81,HYPERCHOLESTEROLAEMIA treats PITAVASTATIN,54,24,,75,36,treats,0.9958932065,206484,"Like the other statins, [PITAVASTATIN] is indicated for [HYPERCHOLESTEROLAEMIA] and for the prevention of cardiovascular disease.",HYPERCHOLESTEROLAEMIA,PITAVASTATIN,TWrex-treat
789214508,9/16/2015 14:18:29,1739526674,9/16/2015 14:17:19,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,no_relation,30,59,,39,74,treats,0.485642931178632,812472,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI,TWrex-cause
789214508,9/16/2015 14:21:14,1739527690,9/16/2015 14:20:55,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,BABESIA MICROTI treats BABESIOSIS,30,59,,39,74,treats,0.485642931178632,812472,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI,TWrex-cause
789214508,9/16/2015 14:36:14,1739533001,9/16/2015 14:35:19,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,BABESIOSIS treats BABESIA MICROTI,30,59,,39,74,treats,0.485642931178632,812472,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI,TWrex-cause
789214508,9/16/2015 14:43:55,1739536008,9/16/2015 14:38:53,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,no_relation,30,59,,39,74,treats,0.485642931178632,812472,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI,TWrex-cause
789214508,9/16/2015 14:54:53,1739540420,9/16/2015 14:54:05,false,bitcoinget,0.7375,20311164,NLD,09,Utrecht,84.105.54.251,no_relation,30,59,,39,74,treats,0.485642931178632,812472,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI,TWrex-cause
789214508,9/16/2015 14:57:22,1739541458,9/16/2015 14:55:32,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,BABESIOSIS treats BABESIA MICROTI,30,59,,39,74,treats,0.485642931178632,812472,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI,TWrex-cause
789214508,9/16/2015 15:00:12,1739542698,9/16/2015 14:58:44,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,BABESIOSIS treats BABESIA MICROTI,30,59,,39,74,treats,0.485642931178632,812472,164  Babesiosis  Treatment of BABESIOSIS   +    caused by  BABESIA MICROTI.,BABESIOSIS,BABESIA MICROTI,TWrex-cause
789214509,9/16/2015 15:00:05,1739542609,9/16/2015 14:59:42,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,FOMEPIZOLE treats ETHYLENE GLYCOL POISONING,68,0,,93,10,treats,0.997054485501581,212610,[FOMEPIZOLE] has been shown to be highly effective as an antidote for [ETHYLENE GLYCOL POISONING].,ETHYLENE GLYCOL POISONING,FOMEPIZOLE,TWrex-treat
789214509,9/16/2015 15:08:21,1739545879,9/16/2015 15:06:54,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,FOMEPIZOLE treats ETHYLENE GLYCOL POISONING,68,0,,93,10,treats,0.997054485501581,212610,[FOMEPIZOLE] has been shown to be highly effective as an antidote for [ETHYLENE GLYCOL POISONING].,ETHYLENE GLYCOL POISONING,FOMEPIZOLE,TWrex-treat
789214509,9/16/2015 15:13:52,1739548188,9/16/2015 15:12:58,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,FOMEPIZOLE treats ETHYLENE GLYCOL POISONING,68,0,,93,10,treats,0.997054485501581,212610,[FOMEPIZOLE] has been shown to be highly effective as an antidote for [ETHYLENE GLYCOL POISONING].,ETHYLENE GLYCOL POISONING,FOMEPIZOLE,TWrex-treat
789214509,9/16/2015 15:13:54,1739548203,9/16/2015 15:13:30,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,ETHYLENE GLYCOL POISONING treats FOMEPIZOLE,68,0,,93,10,treats,0.997054485501581,212610,[FOMEPIZOLE] has been shown to be highly effective as an antidote for [ETHYLENE GLYCOL POISONING].,ETHYLENE GLYCOL POISONING,FOMEPIZOLE,TWrex-treat
789214509,9/16/2015 15:30:44,1739562742,9/16/2015 15:30:36,false,tremorgames,0.5357,24449707,CAN,QC,Laval,96.20.14.148,FOMEPIZOLE treats ETHYLENE GLYCOL POISONING,68,0,,93,10,treats,0.997054485501581,212610,[FOMEPIZOLE] has been shown to be highly effective as an antidote for [ETHYLENE GLYCOL POISONING].,ETHYLENE GLYCOL POISONING,FOMEPIZOLE,TWrex-treat
789214509,9/16/2015 15:34:03,1739565245,9/16/2015 15:33:32,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,FOMEPIZOLE treats ETHYLENE GLYCOL POISONING,68,0,,93,10,treats,0.997054485501581,212610,[FOMEPIZOLE] has been shown to be highly effective as an antidote for [ETHYLENE GLYCOL POISONING].,ETHYLENE GLYCOL POISONING,FOMEPIZOLE,TWrex-treat
789214509,9/16/2015 15:42:36,1739568640,9/16/2015 15:42:13,false,prodege,0.7024,14848125,GBR,V8,Airdrie,86.151.77.161,FOMEPIZOLE treats ETHYLENE GLYCOL POISONING,68,0,,93,10,treats,0.997054485501581,212610,[FOMEPIZOLE] has been shown to be highly effective as an antidote for [ETHYLENE GLYCOL POISONING].,ETHYLENE GLYCOL POISONING,FOMEPIZOLE,TWrex-treat
789214510,9/16/2015 15:57:18,1739575521,9/16/2015 15:56:03,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,NYSTATIN treats ORAL CANDIDIASIS,11,83,,26,91,treats,0.994134846772434,800142,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN,TWrex-cause
789214510,9/16/2015 16:18:22,1739585199,9/16/2015 16:16:41,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,NYSTATIN treats ORAL CANDIDIASIS,11,83,,26,91,treats,0.994134846772434,800142,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN,TWrex-cause
789214510,9/16/2015 16:39:39,1739594515,9/16/2015 16:39:29,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,NYSTATIN treats ORAL CANDIDIASIS,11,83,,26,91,treats,0.994134846772434,800142,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN,TWrex-cause
789214510,9/16/2015 17:26:08,1739616901,9/16/2015 17:25:13,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,NYSTATIN treats ORAL CANDIDIASIS,11,83,,26,91,treats,0.994134846772434,800142,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN,TWrex-cause
789214510,9/16/2015 17:37:21,1739624049,9/16/2015 17:37:07,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,NYSTATIN treats ORAL CANDIDIASIS,11,83,,26,91,treats,0.994134846772434,800142,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN,TWrex-cause
789214510,9/16/2015 17:51:50,1739629958,9/16/2015 17:50:50,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,NYSTATIN treats ORAL CANDIDIASIS,11,83,,26,91,treats,0.994134846772434,800142,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN,TWrex-cause
789214510,9/16/2015 17:52:52,1739630719,9/16/2015 17:52:31,false,prodege,0.881,3587109,CAN,NS,Havre Boucher,142.166.204.244,NYSTATIN treats ORAL CANDIDIASIS,11,83,,26,91,treats,0.994134846772434,800142,"Treatment  ORAL CANDIDIASIS can be treated with topical anti fungal drugs, such as NYSTATIN miconazole, Gentian violet or amphotericin B. Topical therapy is given as an oral suspension which is washed around the mouth and then swallowed by the patient.",ORAL CANDIDIASIS,NYSTATIN,TWrex-cause
789214511,9/16/2015 10:13:30,1739453689,9/16/2015 10:13:10,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,TOPIRAMATE treats DIABETIC NEUROPATHY,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:13:56,1739453801,9/16/2015 10:13:24,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,TOPIRAMATE treats DIABETIC NEUROPATHY,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:14:46,1739454115,9/16/2015 10:13:30,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,TOPIRAMATE treats DIABETIC NEUROPATHY,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:20:27,1739456004,9/16/2015 10:19:41,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,no_relation,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:35:40,1739460488,9/16/2015 10:33:49,false,gifthunterclub,0.7,30884086,AUS,04,"",118.208.145.92,no_relation,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 10:41:38,1739462147,9/16/2015 10:40:45,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,TOPIRAMATE treats DIABETIC NEUROPATHY,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214511,9/16/2015 11:00:15,1739467758,9/16/2015 10:59:46,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,DIABETIC NEUROPATHY treats TOPIRAMATE,35,0,,54,10,treats,0.737209780774486,216955,"[TOPIRAMATE] has not been studied in [DIABETIC NEUROPATHY], but has the beneficial side effect of causing mild anorexia and weight loss, and is anecdotally beneficial.",DIABETIC NEUROPATHY,TOPIRAMATE,TWrex-treat
789214512,9/16/2015 11:05:00,1739469246,9/16/2015 11:04:45,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,CONVENTIONAL AMPHOTERICIN B treats EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,114,37,,158,64,treats,0.874157276121538,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:09:24,1739470291,9/16/2015 11:08:52,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,CONVENTIONAL AMPHOTERICIN B treats EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,114,37,,158,64,treats,0.874157276121538,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:19:21,1739472990,9/16/2015 11:19:04,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,CONVENTIONAL AMPHOTERICIN B treats EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,114,37,,158,64,treats,0.874157276121538,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:20:11,1739473195,9/16/2015 11:19:53,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,no_relation,114,37,,158,64,treats,0.874157276121538,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:26:26,1739474424,9/16/2015 11:25:41,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,no_relation,114,37,,158,64,treats,0.874157276121538,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:26:52,1739474471,9/16/2015 11:26:27,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,no_relation,114,37,,158,64,treats,0.874157276121538,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214512,9/16/2015 11:29:47,1739475211,9/16/2015 11:26:12,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,114,37,,158,64,treats,0.874157276121538,800971,"211 ,   245 ,   293 ,   426 ,   436  CONVENTIONAL AMPHOTERICIN B in HIV infected adults with diffuse pulmonary or EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS: 0.7 1 mg/kg daily.",EXTRATHORACIC DISSEMINATED COCCIDIOIDOMYCOSIS,CONVENTIONAL AMPHOTERICIN B,TWrex-cause
789214513,9/16/2015 09:41:50,1739444632,9/16/2015 09:38:18,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,ATORVASTATIN treats TYPE 2 DIABETES,82,46,,97,58,treats,0.9113223769,209152,"title=Reduction in cardiovascular events with [ATORVASTATIN] in 2,532 patients with [TYPE 2 DIABETES]: Anglo-Scandinavian Cardiac Outcomes Triallipid-lowering arm .",TYPE 2 DIABETES,ATORVASTATIN,TWrex-treat
789214513,9/16/2015 09:44:55,1739445280,9/16/2015 09:44:42,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,ATORVASTATIN treats TYPE 2 DIABETES,82,46,,97,58,treats,0.9113223769,209152,"title=Reduction in cardiovascular events with [ATORVASTATIN] in 2,532 patients with [TYPE 2 DIABETES]: Anglo-Scandinavian Cardiac Outcomes Triallipid-lowering arm .",TYPE 2 DIABETES,ATORVASTATIN,TWrex-treat
789214513,9/16/2015 09:52:23,1739447177,9/16/2015 09:51:54,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,ATORVASTATIN treats TYPE 2 DIABETES,82,46,,97,58,treats,0.9113223769,209152,"title=Reduction in cardiovascular events with [ATORVASTATIN] in 2,532 patients with [TYPE 2 DIABETES]: Anglo-Scandinavian Cardiac Outcomes Triallipid-lowering arm .",TYPE 2 DIABETES,ATORVASTATIN,TWrex-treat
789214513,9/16/2015 09:54:25,1739447779,9/16/2015 09:54:07,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,82,46,,97,58,treats,0.9113223769,209152,"title=Reduction in cardiovascular events with [ATORVASTATIN] in 2,532 patients with [TYPE 2 DIABETES]: Anglo-Scandinavian Cardiac Outcomes Triallipid-lowering arm .",TYPE 2 DIABETES,ATORVASTATIN,TWrex-treat
789214513,9/16/2015 09:54:32,1739447823,9/16/2015 09:54:09,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,82,46,,97,58,treats,0.9113223769,209152,"title=Reduction in cardiovascular events with [ATORVASTATIN] in 2,532 patients with [TYPE 2 DIABETES]: Anglo-Scandinavian Cardiac Outcomes Triallipid-lowering arm .",TYPE 2 DIABETES,ATORVASTATIN,TWrex-treat
789214513,9/16/2015 10:07:41,1739452054,9/16/2015 10:06:00,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,no_relation,82,46,,97,58,treats,0.9113223769,209152,"title=Reduction in cardiovascular events with [ATORVASTATIN] in 2,532 patients with [TYPE 2 DIABETES]: Anglo-Scandinavian Cardiac Outcomes Triallipid-lowering arm .",TYPE 2 DIABETES,ATORVASTATIN,TWrex-treat
789214513,9/16/2015 10:13:29,1739453691,9/16/2015 10:11:53,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,ATORVASTATIN treats TYPE 2 DIABETES,82,46,,97,58,treats,0.9113223769,209152,"title=Reduction in cardiovascular events with [ATORVASTATIN] in 2,532 patients with [TYPE 2 DIABETES]: Anglo-Scandinavian Cardiac Outcomes Triallipid-lowering arm .",TYPE 2 DIABETES,ATORVASTATIN,TWrex-treat
789214514,9/16/2015 15:57:18,1739575540,9/16/2015 15:56:03,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,AMPHOTERICIN B treats NEUTROPENIA,228,187,,238,201,treats,0.991836598134175,800624,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
789214514,9/16/2015 16:18:22,1739585198,9/16/2015 16:16:41,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,NEUTROPENIA treats AMPHOTERICIN B,228,187,,238,201,treats,0.991836598134175,800624,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
789214514,9/16/2015 16:39:39,1739594514,9/16/2015 16:39:29,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,AMPHOTERICIN B treats NEUTROPENIA,228,187,,238,201,treats,0.991836598134175,800624,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
789214514,9/16/2015 17:26:08,1739616907,9/16/2015 17:25:13,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,AMPHOTERICIN B treats NEUTROPENIA,228,187,,238,201,treats,0.991836598134175,800624,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
789214514,9/16/2015 17:37:21,1739624050,9/16/2015 17:37:07,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,AMPHOTERICIN B treats NEUTROPENIA,228,187,,238,201,treats,0.991836598134175,800624,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
789214514,9/16/2015 17:51:50,1739629956,9/16/2015 17:50:50,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,AMPHOTERICIN B treats NEUTROPENIA,228,187,,238,201,treats,0.991836598134175,800624,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
789214514,9/16/2015 17:52:52,1739630715,9/16/2015 17:52:31,false,prodege,0.881,3587109,CAN,NS,Havre Boucher,142.166.204.244,AMPHOTERICIN B treats NEUTROPENIA,228,187,,238,201,treats,0.991836598134175,800624,"The study by Boogaerts and colleagues, although limited by its open design and a slightly older amphotericin B patient group, showed that empiric itraconazole was as effective as empiric AMPHOTERICIN B for eliminating fever and NEUTROPENIA in patients with hematologic cancer.",NEUTROPENIA,AMPHOTERICIN B,TWrex-cause
789214515,9/16/2015 11:29:34,1739475170,9/16/2015 11:28:37,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT treats ANAL FISSURES,46,0,,58,41,treats,0.994134846772434,803942,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT,TWrex-cause
789214515,9/16/2015 11:31:19,1739475574,9/16/2015 11:30:47,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT treats ANAL FISSURES,46,0,,58,41,treats,0.994134846772434,803942,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT,TWrex-cause
789214515,9/16/2015 11:31:36,1739475619,9/16/2015 11:30:38,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT treats ANAL FISSURES,46,0,,58,41,treats,0.994134846772434,803942,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT,TWrex-cause
789214515,9/16/2015 11:33:55,1739476141,9/16/2015 11:33:38,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT treats ANAL FISSURES,46,0,,58,41,treats,0.994134846772434,803942,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT,TWrex-cause
789214515,9/16/2015 11:34:24,1739476330,9/16/2015 11:33:43,false,clixsense,0.9111,21490235,GBR,N7,Woking,86.30.254.232,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT treats ANAL FISSURES,46,0,,58,41,treats,0.994134846772434,803942,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT,TWrex-cause
789214515,9/16/2015 11:45:22,1739479085,9/16/2015 11:45:06,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT treats ANAL FISSURES,46,0,,58,41,treats,0.994134846772434,803942,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT,TWrex-cause
789214515,9/16/2015 11:48:09,1739479823,9/16/2015 11:40:39,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT treats ANAL FISSURES,46,0,,58,41,treats,0.994134846772434,803942,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT,TWrex-cause
789214516,9/16/2015 11:32:04,1739475705,9/16/2015 11:31:54,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,CLOMIPRAMINE treats DEPRESSION,108,75,,117,87,treats,0.971665620577517,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11  1163) vsCLOMIPRAMINE in the treatment of DEPRESSION: a double blind multicenter study in Belgium.",DEPRESSION,CLOMIPRAMINE,TWrex-cause
789214516,9/16/2015 11:42:46,1739478426,9/16/2015 11:42:34,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,no_relation,108,75,,117,87,treats,0.971665620577517,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11  1163) vsCLOMIPRAMINE in the treatment of DEPRESSION: a double blind multicenter study in Belgium.",DEPRESSION,CLOMIPRAMINE,TWrex-cause
789214516,9/16/2015 11:46:11,1739479317,9/16/2015 11:45:56,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,CLOMIPRAMINE treats DEPRESSION,108,75,,117,87,treats,0.971665620577517,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11  1163) vsCLOMIPRAMINE in the treatment of DEPRESSION: a double blind multicenter study in Belgium.",DEPRESSION,CLOMIPRAMINE,TWrex-cause
789214516,9/16/2015 12:03:50,1739483496,9/16/2015 12:03:35,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,CLOMIPRAMINE treats DEPRESSION,108,75,,117,87,treats,0.971665620577517,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11  1163) vsCLOMIPRAMINE in the treatment of DEPRESSION: a double blind multicenter study in Belgium.",DEPRESSION,CLOMIPRAMINE,TWrex-cause
789214516,9/16/2015 12:14:51,1739486160,9/16/2015 12:14:22,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,CLOMIPRAMINE treats DEPRESSION,108,75,,117,87,treats,0.971665620577517,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11  1163) vsCLOMIPRAMINE in the treatment of DEPRESSION: a double blind multicenter study in Belgium.",DEPRESSION,CLOMIPRAMINE,TWrex-cause
789214516,9/16/2015 12:16:12,1739486569,9/16/2015 12:15:56,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,CLOMIPRAMINE treats DEPRESSION,108,75,,117,87,treats,0.971665620577517,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11  1163) vsCLOMIPRAMINE in the treatment of DEPRESSION: a double blind multicenter study in Belgium.",DEPRESSION,CLOMIPRAMINE,TWrex-cause
789214516,9/16/2015 12:29:49,1739489584,9/16/2015 12:29:36,false,instagc,0.8397,13581319,USA,IL,Trenton,208.70.36.12,CLOMIPRAMINE treats DEPRESSION,108,75,,117,87,treats,0.971665620577517,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11  1163) vsCLOMIPRAMINE in the treatment of DEPRESSION: a double blind multicenter study in Belgium.",DEPRESSION,CLOMIPRAMINE,TWrex-cause
789214517,9/16/2015 16:19:27,1739585605,9/16/2015 16:18:47,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,[LOW MOLECULAR WEIGHT HEPARIN] treats [WARFARIN'S TERATOGENICITY],108,18,,133,45,treats,0.437594974493684,214274,"During pregnancy, [LOW MOLECULAR WEIGHT HEPARIN] and low dose aspirin are used instead of warfarin because of [WARFARIN'S TERATOGENICITY]",[WARFARIN'S TERATOGENICITY],[LOW MOLECULAR WEIGHT HEPARIN],TWrex-treat
789214517,9/16/2015 16:40:07,1739594746,9/16/2015 16:39:52,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,no_relation,108,18,,133,45,treats,0.437594974493684,214274,"During pregnancy, [LOW MOLECULAR WEIGHT HEPARIN] and low dose aspirin are used instead of warfarin because of [WARFARIN'S TERATOGENICITY]",[WARFARIN'S TERATOGENICITY],[LOW MOLECULAR WEIGHT HEPARIN],TWrex-treat
789214517,9/16/2015 17:27:16,1739617756,9/16/2015 17:26:34,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,[LOW MOLECULAR WEIGHT HEPARIN] treats [WARFARIN'S TERATOGENICITY],108,18,,133,45,treats,0.437594974493684,214274,"During pregnancy, [LOW MOLECULAR WEIGHT HEPARIN] and low dose aspirin are used instead of warfarin because of [WARFARIN'S TERATOGENICITY]",[WARFARIN'S TERATOGENICITY],[LOW MOLECULAR WEIGHT HEPARIN],TWrex-treat
789214517,9/16/2015 17:38:09,1739624327,9/16/2015 17:37:44,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,no_relation,108,18,,133,45,treats,0.437594974493684,214274,"During pregnancy, [LOW MOLECULAR WEIGHT HEPARIN] and low dose aspirin are used instead of warfarin because of [WARFARIN'S TERATOGENICITY]",[WARFARIN'S TERATOGENICITY],[LOW MOLECULAR WEIGHT HEPARIN],TWrex-treat
789214517,9/16/2015 17:53:03,1739630887,9/16/2015 17:52:37,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,no_relation,108,18,,133,45,treats,0.437594974493684,214274,"During pregnancy, [LOW MOLECULAR WEIGHT HEPARIN] and low dose aspirin are used instead of warfarin because of [WARFARIN'S TERATOGENICITY]",[WARFARIN'S TERATOGENICITY],[LOW MOLECULAR WEIGHT HEPARIN],TWrex-treat
789214517,9/16/2015 17:58:30,1739636861,9/16/2015 17:58:08,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,no_relation,108,18,,133,45,treats,0.437594974493684,214274,"During pregnancy, [LOW MOLECULAR WEIGHT HEPARIN] and low dose aspirin are used instead of warfarin because of [WARFARIN'S TERATOGENICITY]",[WARFARIN'S TERATOGENICITY],[LOW MOLECULAR WEIGHT HEPARIN],TWrex-treat
789214517,9/16/2015 18:13:26,1739658402,9/16/2015 18:13:05,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,no_relation,108,18,,133,45,treats,0.437594974493684,214274,"During pregnancy, [LOW MOLECULAR WEIGHT HEPARIN] and low dose aspirin are used instead of warfarin because of [WARFARIN'S TERATOGENICITY]",[WARFARIN'S TERATOGENICITY],[LOW MOLECULAR WEIGHT HEPARIN],TWrex-treat
789214518,9/16/2015 10:14:59,1739454212,9/16/2015 10:14:43,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,AMPHOTERICIN B treats SPOROTRICHOSIS,139,24,,152,38,treats,0.983869910099907,800548,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
789214518,9/16/2015 10:16:18,1739454683,9/16/2015 10:15:58,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,AMPHOTERICIN B treats SPOROTRICHOSIS,139,24,,152,38,treats,0.983869910099907,800548,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
789214518,9/16/2015 10:44:15,1739462868,9/16/2015 10:43:47,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,AMPHOTERICIN B treats SPOROTRICHOSIS,139,24,,152,38,treats,0.983869910099907,800548,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
789214518,9/16/2015 10:45:41,1739463253,9/16/2015 10:45:04,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,AMPHOTERICIN B treats SPOROTRICHOSIS,139,24,,152,38,treats,0.983869910099907,800548,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
789214518,9/16/2015 10:51:03,1739464997,9/16/2015 10:50:16,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,AMPHOTERICIN B treats SPOROTRICHOSIS,139,24,,152,38,treats,0.983869910099907,800548,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
789214518,9/16/2015 11:01:23,1739468177,9/16/2015 11:01:05,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,AMPHOTERICIN B treats SPOROTRICHOSIS,139,24,,152,38,treats,0.983869910099907,800548,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
789214518,9/16/2015 11:03:56,1739468892,9/16/2015 11:03:22,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,AMPHOTERICIN B treats SPOROTRICHOSIS,139,24,,152,38,treats,0.983869910099907,800548,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B,TWrex-cause
789214519,9/16/2015 10:14:42,1739454072,9/16/2015 10:14:19,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:15:57,1739454589,9/16/2015 10:15:20,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:18:07,1739455390,9/16/2015 10:17:30,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:43:44,1739462676,9/16/2015 10:42:48,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:45:02,1739463087,9/16/2015 10:44:26,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,ABCIXIMAB treats REFRACTORY UNSTABLE ANGINA,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 10:50:15,1739464694,9/16/2015 10:46:57,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,REFRACTORY UNSTABLE ANGINA treats ABCIXIMAB,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214519,9/16/2015 11:01:04,1739468046,9/16/2015 11:00:52,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,no_relation,92,39,,117,48,treats,0.889000889001333,800959,Randomised placebo controlled trial of ABCIXIMAB before and during coronary intervention in REFRACTORY UNSTABLE ANGINA: the CAPTURE study.,REFRACTORY UNSTABLE ANGINA,ABCIXIMAB,TWrex-cause
789214520,9/16/2015 16:19:27,1739585602,9/16/2015 16:18:47,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 16:40:07,1739594743,9/16/2015 16:39:52,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 17:27:16,1739617753,9/16/2015 17:26:34,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 17:38:09,1739624326,9/16/2015 17:37:44,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 17:53:03,1739630882,9/16/2015 17:52:37,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 17:58:30,1739636875,9/16/2015 17:58:08,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214520,9/16/2015 18:13:26,1739658404,9/16/2015 18:13:05,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,DEFERIPRONE AND DEFEROXAMINE (DFO) treats MYOCARDIAL IRON OVERLOAD,134,77,,157,111,treats,0.99654575824488,907233,"Regarding iron chelation treatment, patients receiving combined therapy with DEFERIPRONE AND DEFEROXAMINE (DFO) significantly reduced MYOCARDIAL IRON OVERLOAD during the 4 yr study period, whilst patients in monotherapy with DFO showed a significant increase in LIC.",MYOCARDIAL IRON OVERLOAD,DEFERIPRONE AND DEFEROXAMINE (DFO),RO-may_prevent
789214521,9/16/2015 12:45:05,1739494177,9/16/2015 12:44:44,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,PROPANTHELINE treats IBS,214,115,,216,128,treats,0.961074462327142,803348,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE,TWrex-cause
789214521,9/16/2015 12:46:48,1739494856,9/16/2015 12:46:33,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,PROPANTHELINE treats IBS,214,115,,216,128,treats,0.961074462327142,803348,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE,TWrex-cause
789214521,9/16/2015 13:28:10,1739508242,9/16/2015 13:26:25,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,PROPANTHELINE treats IBS,214,115,,216,128,treats,0.961074462327142,803348,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE,TWrex-cause
789214521,9/16/2015 13:40:57,1739514229,9/16/2015 13:39:26,false,neodev,0.7657,30588889,NLD,07,Amsterdam,77.248.175.222,PROPANTHELINE treats IBS,214,115,,216,128,treats,0.961074462327142,803348,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE,TWrex-cause
789214521,9/16/2015 13:53:23,1739518030,9/16/2015 13:53:07,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,PROPANTHELINE treats IBS,214,115,,216,128,treats,0.961074462327142,803348,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE,TWrex-cause
789214521,9/16/2015 14:00:12,1739520348,9/16/2015 13:59:39,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,PROPANTHELINE treats IBS,214,115,,216,128,treats,0.961074462327142,803348,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE,TWrex-cause
789214521,9/16/2015 14:11:16,1739524228,9/16/2015 14:10:19,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,PROPANTHELINE treats IBS,214,115,,216,128,treats,0.961074462327142,803348,"Antispasmodics, primarily anticholinergic agents (e.g., dicyclomine hydrochloride, clidinium bromide, hyoscyamine, PROPANTHELINE or belladonna alkaloids), can treat cramping abdominal discomfort or the symptoms of IBS that accompany UC and CD.",IBS,PROPANTHELINE,TWrex-cause
789214522,9/16/2015 11:43:43,1739478710,9/16/2015 11:43:12,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,AMOXICILLIN treats ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,98,54,,136,65,treats,1,800940,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN,TWrex-cause
789214522,9/16/2015 11:47:59,1739479782,9/16/2015 11:47:40,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,AMOXICILLIN treats ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,98,54,,136,65,treats,1,800940,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN,TWrex-cause
789214522,9/16/2015 12:04:30,1739483704,9/16/2015 12:04:11,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,AMOXICILLIN treats ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,98,54,,136,65,treats,1,800940,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN,TWrex-cause
789214522,9/16/2015 12:16:35,1739486694,9/16/2015 12:16:27,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,AMOXICILLIN treats ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,98,54,,136,65,treats,1,800940,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN,TWrex-cause
789214522,9/16/2015 12:18:01,1739486977,9/16/2015 12:16:04,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,AMOXICILLIN treats ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,98,54,,136,65,treats,1,800940,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN,TWrex-cause
789214522,9/16/2015 12:30:11,1739489667,9/16/2015 12:30:01,false,instagc,0.8397,13581319,USA,IL,Trenton,208.70.36.12,AMOXICILLIN treats ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,98,54,,136,65,treats,1,800940,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN,TWrex-cause
789214522,9/16/2015 12:43:24,1739493622,9/16/2015 12:42:43,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,AMOXICILLIN treats ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,98,54,,136,65,treats,1,800940,"Russell MD, Nolen T, Allen JM et al. Cefprozil versus AMOXICILLIN/clavulanate in the treatment of ACUTE UNCOMPLICATED MAXILLARY SINUSITIS in adults; a randomized, prospective clinical trial.",ACUTE UNCOMPLICATED MAXILLARY SINUSITIS,AMOXICILLIN,TWrex-cause
789214523,9/16/2015 16:18:42,1739585306,9/16/2015 16:18:26,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,NAPROXEN treats OSTEOARTHRITIS,450,253,,464,261,treats,0.993127066322842,907732,"of intraarticular hyaluronan in osteoarthritis of the knee  Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and ibuprofen in the treatment of osteoarthritis of the knee  Lancet  Comparison of lumiracoxib with NAPROXEN and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial  Pathogenesis and management of pain in OSTEOARTHRITIS  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis.",OSTEOARTHRITIS,NAPROXEN,RO-may_treat
789214523,9/16/2015 16:39:50,1739594599,9/16/2015 16:39:40,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,NAPROXEN treats OSTEOARTHRITIS,450,253,,464,261,treats,0.993127066322842,907732,"of intraarticular hyaluronan in osteoarthritis of the knee  Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and ibuprofen in the treatment of osteoarthritis of the knee  Lancet  Comparison of lumiracoxib with NAPROXEN and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial  Pathogenesis and management of pain in OSTEOARTHRITIS  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis.",OSTEOARTHRITIS,NAPROXEN,RO-may_treat
789214523,9/16/2015 17:26:31,1739617182,9/16/2015 17:26:09,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,NAPROXEN treats OSTEOARTHRITIS,450,253,,464,261,treats,0.993127066322842,907732,"of intraarticular hyaluronan in osteoarthritis of the knee  Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and ibuprofen in the treatment of osteoarthritis of the knee  Lancet  Comparison of lumiracoxib with NAPROXEN and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial  Pathogenesis and management of pain in OSTEOARTHRITIS  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis.",OSTEOARTHRITIS,NAPROXEN,RO-may_treat
789214523,9/16/2015 17:37:43,1739624190,9/16/2015 17:37:23,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,OSTEOARTHRITIS treats NAPROXEN,450,253,,464,261,treats,0.993127066322842,907732,"of intraarticular hyaluronan in osteoarthritis of the knee  Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and ibuprofen in the treatment of osteoarthritis of the knee  Lancet  Comparison of lumiracoxib with NAPROXEN and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial  Pathogenesis and management of pain in OSTEOARTHRITIS  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis.",OSTEOARTHRITIS,NAPROXEN,RO-may_treat
789214523,9/16/2015 17:52:36,1739630506,9/16/2015 17:51:51,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,no_relation,450,253,,464,261,treats,0.993127066322842,907732,"of intraarticular hyaluronan in osteoarthritis of the knee  Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and ibuprofen in the treatment of osteoarthritis of the knee  Lancet  Comparison of lumiracoxib with NAPROXEN and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial  Pathogenesis and management of pain in OSTEOARTHRITIS  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis.",OSTEOARTHRITIS,NAPROXEN,RO-may_treat
789214523,9/16/2015 17:53:01,1739630854,9/16/2015 17:52:53,false,prodege,0.881,3587109,CAN,NS,Havre Boucher,142.166.204.244,NAPROXEN treats OSTEOARTHRITIS,450,253,,464,261,treats,0.993127066322842,907732,"of intraarticular hyaluronan in osteoarthritis of the knee  Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and ibuprofen in the treatment of osteoarthritis of the knee  Lancet  Comparison of lumiracoxib with NAPROXEN and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial  Pathogenesis and management of pain in OSTEOARTHRITIS  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis.",OSTEOARTHRITIS,NAPROXEN,RO-may_treat
789214523,9/16/2015 17:58:07,1739636367,9/16/2015 17:57:24,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,NAPROXEN treats OSTEOARTHRITIS,450,253,,464,261,treats,0.993127066322842,907732,"of intraarticular hyaluronan in osteoarthritis of the knee  Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and ibuprofen in the treatment of osteoarthritis of the knee  Lancet  Comparison of lumiracoxib with NAPROXEN and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial  Pathogenesis and management of pain in OSTEOARTHRITIS  Acupuncture in patients with osteoarthritis of the knee: a randomised trial  Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis.",OSTEOARTHRITIS,NAPROXEN,RO-may_treat
789214524,9/16/2015 15:14:19,1739548432,9/16/2015 15:13:56,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,DERMATOPHYTE TOE ONYCHOMYCOSIS treats CICLOPIROX NAIL LACQUER SOLUTION,114,29,,143,61,treats,0.997054485501581,804289,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION,TWrex-cause
789214524,9/16/2015 15:15:20,1739548845,9/16/2015 15:13:53,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,DERMATOPHYTE TOE ONYCHOMYCOSIS treats CICLOPIROX NAIL LACQUER SOLUTION,114,29,,143,61,treats,0.997054485501581,804289,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION,TWrex-cause
789214524,9/16/2015 15:42:57,1739568792,9/16/2015 15:42:38,false,prodege,0.7024,14848125,GBR,V8,Airdrie,86.151.77.161,CICLOPIROX NAIL LACQUER SOLUTION treats DERMATOPHYTE TOE ONYCHOMYCOSIS,114,29,,143,61,treats,0.997054485501581,804289,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION,TWrex-cause
789214524,9/16/2015 15:49:10,1739571830,9/16/2015 15:45:15,false,instagc,0.7897,33467170,USA,WV,Martinsburg,76.106.109.7,CICLOPIROX NAIL LACQUER SOLUTION treats DERMATOPHYTE TOE ONYCHOMYCOSIS,114,29,,143,61,treats,0.997054485501581,804289,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION,TWrex-cause
789214524,9/16/2015 15:53:19,1739573713,9/16/2015 15:52:54,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,CICLOPIROX NAIL LACQUER SOLUTION treats DERMATOPHYTE TOE ONYCHOMYCOSIS,114,29,,143,61,treats,0.997054485501581,804289,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION,TWrex-cause
789214524,9/16/2015 16:02:20,1739578057,9/16/2015 16:02:05,false,bitcoinget,0.8667,21743413,USA,WA,Port Angeles,24.113.29.97,CICLOPIROX NAIL LACQUER SOLUTION treats DERMATOPHYTE TOE ONYCHOMYCOSIS,114,29,,143,61,treats,0.997054485501581,804289,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION,TWrex-cause
789214524,9/16/2015 16:03:07,1739578517,9/16/2015 16:02:46,false,instagc,0.6012,32352104,USA,ME,Bangor,74.75.63.81,DERMATOPHYTE TOE ONYCHOMYCOSIS treats CICLOPIROX NAIL LACQUER SOLUTION,114,29,,143,61,treats,0.997054485501581,804289,Pharmacoeconomic analysis of CICLOPIROX NAIL LACQUER SOLUTION 8% and the new oral antifungal agents used to treat DERMATOPHYTE TOE ONYCHOMYCOSIS in the United States.,DERMATOPHYTE TOE ONYCHOMYCOSIS,CICLOPIROX NAIL LACQUER SOLUTION,TWrex-cause
789214525,9/16/2015 14:21:05,1739527632,9/16/2015 14:20:30,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.986393923832144,903537,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
789214525,9/16/2015 14:48:05,1739537590,9/16/2015 14:47:48,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.986393923832144,903537,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
789214525,9/16/2015 14:59:24,1739542280,9/16/2015 14:58:46,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.986393923832144,903537,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
789214525,9/16/2015 15:05:08,1739544683,9/16/2015 15:04:01,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.986393923832144,903537,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
789214525,9/16/2015 15:11:51,1739547371,9/16/2015 15:10:40,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST treats OPIOID DEPENDENCE,0,89,,46,106,treats,0.986393923832144,903537,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
789214525,9/16/2015 15:12:59,1739547803,9/16/2015 15:12:22,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,OPIOID DEPENDENCE treats BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,0,89,,46,106,treats,0.986393923832144,903537,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
789214525,9/16/2015 15:13:47,1739548181,9/16/2015 15:13:04,false,clixsense,0.3143,6336109,CAN,BC,Prince George,198.254.211.52,no_relation,0,89,,46,106,treats,0.986393923832144,903537,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST is being investigated as a treatment for OPIOID DEPENDENCE,BUPRENORPHINE A MIXED OPIOID AGONIST ANTAGONIST,OPIOID DEPENDENCE,RO-has_causative_agent
789214526,9/16/2015 17:28:04,1739618266,9/16/2015 17:27:27,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 17:38:24,1739624490,9/16/2015 17:38:10,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 17:53:25,1739631271,9/16/2015 17:53:04,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 17:58:52,1739637297,9/16/2015 17:58:31,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 18:13:39,1739658755,9/16/2015 18:13:26,false,clixsense,0.881,9001027,CAN,QC,Dollard-des-ormeaux,96.21.122.219,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 18:15:15,1739661755,9/16/2015 18:13:32,false,elite,0.875,31883685,GBR,"","",79.66.244.188,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214526,9/16/2015 18:23:04,1739677100,9/16/2015 18:22:32,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,THALIDOMIDE treats ERYTHEMA NODOSUM LEPROSUM,25,0,,49,11,treats,0.979957887012223,804706,THALIDOMIDE approved for ERYTHEMA NODOSUM LEPROSUM.,ERYTHEMA NODOSUM LEPROSUM,THALIDOMIDE,TWrex-cause
789214527,9/16/2015 09:37:28,1739443459,9/16/2015 09:36:15,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,no_relation,69,113,,93,128,treats,0.486664263392288,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 09:44:26,1739445188,9/16/2015 09:44:11,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,no_relation,69,113,,93,128,treats,0.486664263392288,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 09:50:50,1739446710,9/16/2015 09:50:24,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,no_relation,69,113,,93,128,treats,0.486664263392288,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 09:53:45,1739447570,9/16/2015 09:53:17,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,69,113,,93,128,treats,0.486664263392288,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 09:53:51,1739447598,9/16/2015 09:53:35,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,69,113,,93,128,treats,0.486664263392288,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 10:04:16,1739450861,9/16/2015 10:04:10,false,clixsense,0.4905,19162475,GBR,P8,Trowbridge,82.33.126.30,MARFAN SYNDROME treats ASCENDING AORTIC ANEURYSM,69,113,,93,128,treats,0.486664263392288,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214527,9/16/2015 10:04:56,1739451167,9/16/2015 10:03:58,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,no_relation,69,113,,93,128,treats,0.486664263392288,813266,"At some high volume centers, the threshold for elective repair of an ASCENDING AORTIC ANEURYSM in a patient with MARFAN SYNDROME may be even lower.",ASCENDING AORTIC ANEURYSM,MARFAN SYNDROME,TWrex-cause
789214528,9/16/2015 09:43:01,1739444915,9/16/2015 09:41:52,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,[DADLE] treats [MEAN ARTERIAL BLOOD PRESSURE],56,15,,83,19,treats,0.722315118514615,211797,Treatment with [DADLE] results in transient depression of [MEAN ARTERIAL BLOOD PRESSURE] and heart rate.,[MEAN ARTERIAL BLOOD PRESSURE],[DADLE],TWrex-treat
789214528,9/16/2015 09:45:11,1739445353,9/16/2015 09:45:00,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,[DADLE] treats [MEAN ARTERIAL BLOOD PRESSURE],56,15,,83,19,treats,0.722315118514615,211797,Treatment with [DADLE] results in transient depression of [MEAN ARTERIAL BLOOD PRESSURE] and heart rate.,[MEAN ARTERIAL BLOOD PRESSURE],[DADLE],TWrex-treat
789214528,9/16/2015 09:52:56,1739447344,9/16/2015 09:52:24,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,[DADLE] treats [MEAN ARTERIAL BLOOD PRESSURE],56,15,,83,19,treats,0.722315118514615,211797,Treatment with [DADLE] results in transient depression of [MEAN ARTERIAL BLOOD PRESSURE] and heart rate.,[MEAN ARTERIAL BLOOD PRESSURE],[DADLE],TWrex-treat
789214528,9/16/2015 09:54:45,1739447884,9/16/2015 09:54:26,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,[DADLE] treats [MEAN ARTERIAL BLOOD PRESSURE],56,15,,83,19,treats,0.722315118514615,211797,Treatment with [DADLE] results in transient depression of [MEAN ARTERIAL BLOOD PRESSURE] and heart rate.,[MEAN ARTERIAL BLOOD PRESSURE],[DADLE],TWrex-treat
789214528,9/16/2015 09:55:01,1739447965,9/16/2015 09:54:34,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,[DADLE] treats [MEAN ARTERIAL BLOOD PRESSURE],56,15,,83,19,treats,0.722315118514615,211797,Treatment with [DADLE] results in transient depression of [MEAN ARTERIAL BLOOD PRESSURE] and heart rate.,[MEAN ARTERIAL BLOOD PRESSURE],[DADLE],TWrex-treat
789214528,9/16/2015 10:08:39,1739452387,9/16/2015 10:07:42,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,[DADLE] treats [MEAN ARTERIAL BLOOD PRESSURE],56,15,,83,19,treats,0.722315118514615,211797,Treatment with [DADLE] results in transient depression of [MEAN ARTERIAL BLOOD PRESSURE] and heart rate.,[MEAN ARTERIAL BLOOD PRESSURE],[DADLE],TWrex-treat
789214528,9/16/2015 10:13:23,1739453672,9/16/2015 10:12:33,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,no_relation,56,15,,83,19,treats,0.722315118514615,211797,Treatment with [DADLE] results in transient depression of [MEAN ARTERIAL BLOOD PRESSURE] and heart rate.,[MEAN ARTERIAL BLOOD PRESSURE],[DADLE],TWrex-treat
789214529,9/16/2015 10:13:41,1739453735,9/16/2015 10:13:30,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,ANTIEPILEPTIC DRUG TREATMENT treats EPILEPSY,103,64,,110,92,treats,0.99654575824488,800640,"Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred ANTIEPILEPTIC DRUG TREATMENT for early EPILEPSY and single seizures: a randomised controlled trial.",EPILEPSY,ANTIEPILEPTIC DRUG TREATMENT,TWrex-cause
789214529,9/16/2015 10:14:25,1739454013,9/16/2015 10:13:57,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,ANTIEPILEPTIC DRUG TREATMENT treats EPILEPSY,103,64,,110,92,treats,0.99654575824488,800640,"Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred ANTIEPILEPTIC DRUG TREATMENT for early EPILEPSY and single seizures: a randomised controlled trial.",EPILEPSY,ANTIEPILEPTIC DRUG TREATMENT,TWrex-cause
789214529,9/16/2015 10:15:18,1739454326,9/16/2015 10:14:47,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,ANTIEPILEPTIC DRUG TREATMENT treats EPILEPSY,103,64,,110,92,treats,0.99654575824488,800640,"Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred ANTIEPILEPTIC DRUG TREATMENT for early EPILEPSY and single seizures: a randomised controlled trial.",EPILEPSY,ANTIEPILEPTIC DRUG TREATMENT,TWrex-cause
789214529,9/16/2015 10:42:07,1739462307,9/16/2015 10:41:40,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,ANTIEPILEPTIC DRUG TREATMENT treats EPILEPSY,103,64,,110,92,treats,0.99654575824488,800640,"Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred ANTIEPILEPTIC DRUG TREATMENT for early EPILEPSY and single seizures: a randomised controlled trial.",EPILEPSY,ANTIEPILEPTIC DRUG TREATMENT,TWrex-cause
789214529,9/16/2015 10:43:42,1739462664,9/16/2015 10:43:15,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,ANTIEPILEPTIC DRUG TREATMENT treats EPILEPSY,103,64,,110,92,treats,0.99654575824488,800640,"Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred ANTIEPILEPTIC DRUG TREATMENT for early EPILEPSY and single seizures: a randomised controlled trial.",EPILEPSY,ANTIEPILEPTIC DRUG TREATMENT,TWrex-cause
789214529,9/16/2015 10:45:53,1739463331,9/16/2015 10:44:43,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,ANTIEPILEPTIC DRUG TREATMENT treats EPILEPSY,103,64,,110,92,treats,0.99654575824488,800640,"Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred ANTIEPILEPTIC DRUG TREATMENT for early EPILEPSY and single seizures: a randomised controlled trial.",EPILEPSY,ANTIEPILEPTIC DRUG TREATMENT,TWrex-cause
789214529,9/16/2015 11:00:29,1739467831,9/16/2015 11:00:15,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,ANTIEPILEPTIC DRUG TREATMENT treats EPILEPSY,103,64,,110,92,treats,0.99654575824488,800640,"Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred ANTIEPILEPTIC DRUG TREATMENT for early EPILEPSY and single seizures: a randomised controlled trial.",EPILEPSY,ANTIEPILEPTIC DRUG TREATMENT,TWrex-cause
789214530,9/16/2015 11:43:11,1739478551,9/16/2015 11:42:46,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,FORSKOLIN treats GLAUCOMA,60,0,,68,9,treats,0.997054485501581,222338,[FORSKOLIN] may be helpful to control the underlying cause of [GLAUCOMA].,GLAUCOMA,FORSKOLIN,TWrex-treat
789214530,9/16/2015 11:47:39,1739479691,9/16/2015 11:46:12,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,FORSKOLIN treats GLAUCOMA,60,0,,68,9,treats,0.997054485501581,222338,[FORSKOLIN] may be helpful to control the underlying cause of [GLAUCOMA].,GLAUCOMA,FORSKOLIN,TWrex-treat
789214530,9/16/2015 12:04:09,1739483571,9/16/2015 12:03:51,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,FORSKOLIN treats GLAUCOMA,60,0,,68,9,treats,0.997054485501581,222338,[FORSKOLIN] may be helpful to control the underlying cause of [GLAUCOMA].,GLAUCOMA,FORSKOLIN,TWrex-treat
789214530,9/16/2015 12:16:02,1739486533,9/16/2015 12:14:52,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,FORSKOLIN treats GLAUCOMA,60,0,,68,9,treats,0.997054485501581,222338,[FORSKOLIN] may be helpful to control the underlying cause of [GLAUCOMA].,GLAUCOMA,FORSKOLIN,TWrex-treat
789214530,9/16/2015 12:16:25,1739486602,9/16/2015 12:16:13,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,FORSKOLIN treats GLAUCOMA,60,0,,68,9,treats,0.997054485501581,222338,[FORSKOLIN] may be helpful to control the underlying cause of [GLAUCOMA].,GLAUCOMA,FORSKOLIN,TWrex-treat
789214530,9/16/2015 12:30:01,1739489618,9/16/2015 12:29:50,false,instagc,0.8397,13581319,USA,IL,Trenton,208.70.36.12,FORSKOLIN treats GLAUCOMA,60,0,,68,9,treats,0.997054485501581,222338,[FORSKOLIN] may be helpful to control the underlying cause of [GLAUCOMA].,GLAUCOMA,FORSKOLIN,TWrex-treat
789214530,9/16/2015 12:53:36,1739496951,9/16/2015 12:53:26,false,instagc,0.8661,15577915,USA,IL,Trenton,208.70.36.12,FORSKOLIN treats GLAUCOMA,60,0,,68,9,treats,0.997054485501581,222338,[FORSKOLIN] may be helpful to control the underlying cause of [GLAUCOMA].,GLAUCOMA,FORSKOLIN,TWrex-treat
789214531,9/16/2015 11:05:41,1739469395,9/16/2015 11:05:15,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,no_relation,8,16,,11,52,treats,0.433012701892219,805278,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
789214531,9/16/2015 11:10:17,1739470439,9/16/2015 11:10:02,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,INTRAARTICULAR HYALURONATE INJECTION treats PAIN,8,16,,11,52,treats,0.433012701892219,805278,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
789214531,9/16/2015 11:20:04,1739473188,9/16/2015 11:19:47,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,INTRAARTICULAR HYALURONATE INJECTION treats PAIN,8,16,,11,52,treats,0.433012701892219,805278,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
789214531,9/16/2015 11:21:18,1739473467,9/16/2015 11:20:36,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,no_relation,8,16,,11,52,treats,0.433012701892219,805278,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
789214531,9/16/2015 11:27:11,1739474585,9/16/2015 11:26:49,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,no_relation,8,16,,11,52,treats,0.433012701892219,805278,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
789214531,9/16/2015 11:27:18,1739474600,9/16/2015 11:27:13,false,elite,0.5833,33798502,USA,DE,"",108.59.8.208,PAIN treats INTRAARTICULAR HYALURONATE INJECTION,8,16,,11,52,treats,0.433012701892219,805278,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
789214531,9/16/2015 11:28:43,1739474958,9/16/2015 11:27:56,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,no_relation,8,16,,11,52,treats,0.433012701892219,805278,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION,TWrex-cause
789214532,9/16/2015 09:36:13,1739443143,9/16/2015 09:35:28,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 09:44:10,1739445114,9/16/2015 09:43:55,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 09:50:23,1739446591,9/16/2015 09:50:02,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 09:53:09,1739447361,9/16/2015 09:52:48,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 09:53:35,1739447520,9/16/2015 09:53:25,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,101,65,,128,77,treats,1,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 10:03:57,1739450790,9/16/2015 10:03:20,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214532,9/16/2015 10:04:10,1739450828,9/16/2015 10:03:56,false,clixsense,0.4905,19162475,GBR,P8,Trowbridge,82.33.126.30,CHLORAMBUCIL treats CHRONIC LYMPHOCYTIC LEUKEMIA,101,65,,128,77,treats,1,803415,"Rai K, Peterson B, Appelbaum F, et al. Fludarabine compared with CHLORAMBUCIL as primary therapy for CHRONIC LYMPHOCYTIC LEUKEMIA",CHRONIC LYMPHOCYTIC LEUKEMIA,CHLORAMBUCIL,TWrex-cause
789214533,9/16/2015 09:35:27,1739442918,9/16/2015 09:29:47,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,no_relation,144,186,,162,219,treats,0.340502612303499,810943,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
789214533,9/16/2015 09:43:54,1739445097,9/16/2015 09:43:35,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,no_relation,144,186,,162,219,treats,0.340502612303499,810943,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
789214533,9/16/2015 09:50:01,1739446485,9/16/2015 09:48:35,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,no_relation,144,186,,162,219,treats,0.340502612303499,810943,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
789214533,9/16/2015 09:52:48,1739447316,9/16/2015 09:52:28,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,ENTEROTOXIGENIC  ESCHERICHIA COLI treats TRAVELERS' DIARRHEA,144,186,,162,219,treats,0.340502612303499,810943,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
789214533,9/16/2015 09:53:21,1739447425,9/16/2015 09:52:57,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,ENTEROTOXIGENIC  ESCHERICHIA COLI treats TRAVELERS' DIARRHEA,144,186,,162,219,treats,0.340502612303499,810943,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
789214533,9/16/2015 10:03:19,1739450581,9/16/2015 10:02:03,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,no_relation,144,186,,162,219,treats,0.340502612303499,810943,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
789214533,9/16/2015 10:03:55,1739450783,9/16/2015 10:03:44,false,clixsense,0.4905,19162475,GBR,P8,Trowbridge,82.33.126.30,ENTEROTOXIGENIC  ESCHERICHIA COLI treats TRAVELERS' DIARRHEA,144,186,,162,219,treats,0.340502612303499,810943,"302 ,   321  Data are limited regarding safety of repeated use of co trimoxazole in pediatric patients   186 ,   a  GI Infections  Treatment of TRAVELERS' DIARRHEA caused by susceptible ENTEROTOXIGENIC  ESCHERICHIA COLI",TRAVELERS' DIARRHEA,ENTEROTOXIGENIC  ESCHERICHIA COLI,TWrex-cause
789214534,9/16/2015 10:14:18,1739453976,9/16/2015 10:13:41,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.970142500145332,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:15:18,1739454327,9/16/2015 10:14:27,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.970142500145332,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:17:29,1739455151,9/16/2015 10:15:19,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.970142500145332,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:42:45,1739462429,9/16/2015 10:42:09,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.970142500145332,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:44:24,1739462921,9/16/2015 10:43:43,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,ESTROGEN treats POSTMENOPAUSAL BONE LOSS,73,106,,97,114,treats,0.970142500145332,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 10:46:55,1739463683,9/16/2015 10:45:54,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,POSTMENOPAUSAL BONE LOSS treats ESTROGEN,73,106,,97,114,treats,0.970142500145332,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214534,9/16/2015 11:00:51,1739467971,9/16/2015 11:00:30,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,no_relation,73,106,,97,114,treats,0.970142500145332,907345,"In order to evaluate the preventive effect of estrogen and vitamin D3 on POSTMENOPAUSAL BONE LOSS, either ESTROGEN (Premarin 0.625 mg/day) or vitamin D3 (Onealfa 1.0 micrograms/day) was administered to postmenopausal women",POSTMENOPAUSAL BONE LOSS,ESTROGEN,RO-may_prevent
789214535,9/16/2015 17:38:37,1739624572,9/16/2015 17:38:24,false,gifthunterclub,0.8792,29582088,GBR,I2,Manchester,92.19.111.82,FLUOXETINE treats OBSESSIVE COMPULSIVE DISORDER,82,51,,111,61,treats,0.983078304622849,907730,"Fontaine R, Chouinard G. An open clinical trial of FLUOXETINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUOXETINE,RO-may_treat
789214535,9/16/2015 17:53:53,1739631739,9/16/2015 17:53:27,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,FLUOXETINE treats OBSESSIVE COMPULSIVE DISORDER,82,51,,111,61,treats,0.983078304622849,907730,"Fontaine R, Chouinard G. An open clinical trial of FLUOXETINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUOXETINE,RO-may_treat
789214535,9/16/2015 17:59:21,1739637907,9/16/2015 17:58:53,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,FLUOXETINE treats OBSESSIVE COMPULSIVE DISORDER,82,51,,111,61,treats,0.983078304622849,907730,"Fontaine R, Chouinard G. An open clinical trial of FLUOXETINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUOXETINE,RO-may_treat
789214535,9/16/2015 18:15:51,1739662825,9/16/2015 18:15:16,false,elite,0.875,31883685,GBR,"","",79.66.244.188,FLUOXETINE treats OBSESSIVE COMPULSIVE DISORDER,82,51,,111,61,treats,0.983078304622849,907730,"Fontaine R, Chouinard G. An open clinical trial of FLUOXETINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUOXETINE,RO-may_treat
789214535,9/16/2015 18:23:27,1739677832,9/16/2015 18:23:05,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,FLUOXETINE treats OBSESSIVE COMPULSIVE DISORDER,82,51,,111,61,treats,0.983078304622849,907730,"Fontaine R, Chouinard G. An open clinical trial of FLUOXETINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUOXETINE,RO-may_treat
789214535,9/16/2015 18:27:20,1739686239,9/16/2015 18:26:55,false,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,FLUOXETINE treats OBSESSIVE COMPULSIVE DISORDER,82,51,,111,61,treats,0.983078304622849,907730,"Fontaine R, Chouinard G. An open clinical trial of FLUOXETINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUOXETINE,RO-may_treat
789214535,9/16/2015 18:52:35,1739748327,9/16/2015 18:50:52,false,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,FLUOXETINE treats OBSESSIVE COMPULSIVE DISORDER,82,51,,111,61,treats,0.983078304622849,907730,"Fontaine R, Chouinard G. An open clinical trial of FLUOXETINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUOXETINE,RO-may_treat
789214536,9/16/2015 15:14:56,1739548702,9/16/2015 15:14:22,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.565685424949238,907106,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
789214536,9/16/2015 15:43:15,1739568891,9/16/2015 15:42:59,false,prodege,0.7024,14848125,GBR,V8,Airdrie,86.151.77.161,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.565685424949238,907106,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
789214536,9/16/2015 15:49:33,1739571987,9/16/2015 15:49:26,false,instagc,0.7897,33467170,USA,WV,Martinsburg,76.106.109.7,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.565685424949238,907106,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
789214536,9/16/2015 15:53:48,1739573885,9/16/2015 15:53:20,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.565685424949238,907106,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
789214536,9/16/2015 16:02:30,1739578163,9/16/2015 16:02:22,false,bitcoinget,0.8667,21743413,USA,WA,Port Angeles,24.113.29.97,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.565685424949238,907106,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
789214536,9/16/2015 16:03:13,1739578606,9/16/2015 16:03:07,false,instagc,0.6012,32352104,USA,ME,Bangor,74.75.63.81,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.565685424949238,907106,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
789214536,9/16/2015 16:04:27,1739579210,9/16/2015 16:04:18,false,neodev,0.9167,33155316,GBR,I9,Dereham,31.50.244.140,SODIUM FLUORIDE treats DENTAL CARIES,181,69,,193,84,treats,0.565685424949238,907106,"A sample of 1,824 schoolchildren was randomly assigned to either the SODIUM FLUORIDE dentifrice or the stannous fluoride dentifrice and examined clinically and radiographically for DENTAL CARIES initially and after one, two, and three years of dentifrice usage.",DENTAL CARIES,SODIUM FLUORIDE,RO-may_prevent
789214537,9/16/2015 09:36:13,1739443144,9/16/2015 09:35:28,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,DIPHTHERIA TOXOID IMMUNIZATION treats DIPHTHERIA,3,3,,12,33,treats,0.997054485501581,804469,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION,TWrex-cause
789214537,9/16/2015 09:44:10,1739445124,9/16/2015 09:43:55,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,DIPHTHERIA TOXOID IMMUNIZATION treats DIPHTHERIA,3,3,,12,33,treats,0.997054485501581,804469,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION,TWrex-cause
789214537,9/16/2015 09:50:23,1739446601,9/16/2015 09:50:02,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,DIPHTHERIA TOXOID IMMUNIZATION treats DIPHTHERIA,3,3,,12,33,treats,0.997054485501581,804469,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION,TWrex-cause
789214537,9/16/2015 09:53:09,1739447366,9/16/2015 09:52:48,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,DIPHTHERIA TOXOID IMMUNIZATION treats DIPHTHERIA,3,3,,12,33,treats,0.997054485501581,804469,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION,TWrex-cause
789214537,9/16/2015 09:53:35,1739447519,9/16/2015 09:53:25,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,3,3,,12,33,treats,0.997054485501581,804469,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION,TWrex-cause
789214537,9/16/2015 10:03:57,1739450787,9/16/2015 10:03:20,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,no_relation,3,3,,12,33,treats,0.997054485501581,804469,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION,TWrex-cause
789214537,9/16/2015 10:04:10,1739450826,9/16/2015 10:03:56,false,clixsense,0.4905,19162475,GBR,P8,Trowbridge,82.33.126.30,DIPHTHERIA TOXOID IMMUNIZATION treats DIPHTHERIA,3,3,,12,33,treats,0.997054485501581,804469,3  DIPHTHERIA TOXOID IMMUNIZATION prevents the serious complications of DIPHTHERIA alleviating the clinical manifestations of the disease by blocking the toxin's ability to enter cells.,DIPHTHERIA,DIPHTHERIA TOXOID IMMUNIZATION,TWrex-cause
789214538,9/16/2015 10:14:59,1739454193,9/16/2015 10:14:43,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.995893206467704,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 10:16:18,1739454688,9/16/2015 10:15:58,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.995893206467704,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 10:44:15,1739462872,9/16/2015 10:43:47,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.995893206467704,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 10:45:41,1739463251,9/16/2015 10:45:04,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.995893206467704,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 10:51:03,1739464996,9/16/2015 10:50:16,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,HYPOTHYROIDISM treats LEVOTHYROXINE,84,41,,97,54,treats,0.995893206467704,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 11:01:23,1739468176,9/16/2015 11:01:05,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.995893206467704,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214538,9/16/2015 11:03:56,1739468893,9/16/2015 11:03:22,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,LEVOTHYROXINE treats HYPOTHYROIDISM,84,41,,97,54,treats,0.995893206467704,800221,Bioequivalence of generic and brand name LEVOTHYROXINE products in the treatment of HYPOTHYROIDISM,HYPOTHYROIDISM,LEVOTHYROXINE,TWrex-cause
789214539,9/16/2015 10:14:18,1739453975,9/16/2015 10:13:41,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,no_relation,162,91,,170,106,treats,0.493196961916072,220763,full immunization against flu provided about a 75 percent effectiveness rate in preventing [HOSPITALIZATIONS] from influenza complications in the 2005 6 and 2006 7 [INFLUENZA] seasons..,[INFLUENZA],[HOSPITALIZATIONS],TWrex-treat
789214539,9/16/2015 10:15:18,1739454331,9/16/2015 10:14:27,false,neodev,0.9167,30627835,GBR,D8,Bishop Auckland,217.44.84.223,no_relation,162,91,,170,106,treats,0.493196961916072,220763,full immunization against flu provided about a 75 percent effectiveness rate in preventing [HOSPITALIZATIONS] from influenza complications in the 2005 6 and 2006 7 [INFLUENZA] seasons..,[INFLUENZA],[HOSPITALIZATIONS],TWrex-treat
789214539,9/16/2015 10:17:29,1739455155,9/16/2015 10:15:19,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,no_relation,162,91,,170,106,treats,0.493196961916072,220763,full immunization against flu provided about a 75 percent effectiveness rate in preventing [HOSPITALIZATIONS] from influenza complications in the 2005 6 and 2006 7 [INFLUENZA] seasons..,[INFLUENZA],[HOSPITALIZATIONS],TWrex-treat
789214539,9/16/2015 10:42:45,1739462427,9/16/2015 10:42:09,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,[HOSPITALIZATIONS] treats [INFLUENZA],162,91,,170,106,treats,0.493196961916072,220763,full immunization against flu provided about a 75 percent effectiveness rate in preventing [HOSPITALIZATIONS] from influenza complications in the 2005 6 and 2006 7 [INFLUENZA] seasons..,[INFLUENZA],[HOSPITALIZATIONS],TWrex-treat
789214539,9/16/2015 10:44:24,1739462919,9/16/2015 10:43:43,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,[HOSPITALIZATIONS] treats [INFLUENZA],162,91,,170,106,treats,0.493196961916072,220763,full immunization against flu provided about a 75 percent effectiveness rate in preventing [HOSPITALIZATIONS] from influenza complications in the 2005 6 and 2006 7 [INFLUENZA] seasons..,[INFLUENZA],[HOSPITALIZATIONS],TWrex-treat
789214539,9/16/2015 10:46:55,1739463679,9/16/2015 10:45:54,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,[HOSPITALIZATIONS] treats [INFLUENZA],162,91,,170,106,treats,0.493196961916072,220763,full immunization against flu provided about a 75 percent effectiveness rate in preventing [HOSPITALIZATIONS] from influenza complications in the 2005 6 and 2006 7 [INFLUENZA] seasons..,[INFLUENZA],[HOSPITALIZATIONS],TWrex-treat
789214539,9/16/2015 11:00:51,1739467969,9/16/2015 11:00:30,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,no_relation,162,91,,170,106,treats,0.493196961916072,220763,full immunization against flu provided about a 75 percent effectiveness rate in preventing [HOSPITALIZATIONS] from influenza complications in the 2005 6 and 2006 7 [INFLUENZA] seasons..,[INFLUENZA],[HOSPITALIZATIONS],TWrex-treat
789214540,9/16/2015 18:17:45,1739666391,9/16/2015 18:17:31,false,elite,0.875,31883685,GBR,"","",79.66.244.188,WARFARIN treats STROKES,179,150,,185,158,treats,0.961523947640823,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 18:25:34,1739682324,9/16/2015 18:24:54,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,WARFARIN treats STROKES,179,150,,185,158,treats,0.961523947640823,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 18:29:02,1739690128,9/16/2015 18:28:53,false,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,WARFARIN treats STROKES,179,150,,185,158,treats,0.961523947640823,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 18:56:12,1739757615,9/16/2015 18:54:39,false,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,no_relation,179,150,,185,158,treats,0.961523947640823,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 19:08:38,1739773951,9/16/2015 19:07:41,false,neodev,0.704,11026968,CAN,ON,Ottawa,108.168.124.170,no_relation,179,150,,185,158,treats,0.961523947640823,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 19:28:02,1739783565,9/16/2015 19:27:44,false,clixsense,0.8036,23197581,NLD,11,Den Haag,82.217.6.160,WARFARIN treats STROKES,179,150,,185,158,treats,0.961523947640823,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214540,9/16/2015 19:29:47,1739784334,9/16/2015 19:29:39,false,instagc,0.75,16469970,USA,OK,Broken Arrow,72.192.89.181,WARFARIN treats STROKES,179,150,,185,158,treats,0.961523947640823,805135,"Anticoagulation with warfarin in patients with atrial fibrillation significantly reduces the risk of stroke; in one meta analysis, patients receiving WARFARIN had a third as many STROKES as did control subjects.",STROKES,WARFARIN,TWrex-cause
789214541,9/16/2015 11:43:43,1739478707,9/16/2015 11:43:12,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,LATENT TUBERCULOSIS INFECTION treats ISONIAZID THERAPY,158,136,,186,153,treats,0.979957887012223,803727,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY,TWrex-cause
789214541,9/16/2015 11:47:59,1739479776,9/16/2015 11:47:40,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,ISONIAZID THERAPY treats LATENT TUBERCULOSIS INFECTION,158,136,,186,153,treats,0.979957887012223,803727,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY,TWrex-cause
789214541,9/16/2015 12:04:30,1739483713,9/16/2015 12:04:11,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,ISONIAZID THERAPY treats LATENT TUBERCULOSIS INFECTION,158,136,,186,153,treats,0.979957887012223,803727,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY,TWrex-cause
789214541,9/16/2015 12:16:35,1739486693,9/16/2015 12:16:27,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,ISONIAZID THERAPY treats LATENT TUBERCULOSIS INFECTION,158,136,,186,153,treats,0.979957887012223,803727,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY,TWrex-cause
789214541,9/16/2015 12:18:01,1739486970,9/16/2015 12:16:04,false,instagc,0.7488,16573689,USA,MI,Hanover,74.45.203.252,ISONIAZID THERAPY treats LATENT TUBERCULOSIS INFECTION,158,136,,186,153,treats,0.979957887012223,803727,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY,TWrex-cause
789214541,9/16/2015 12:30:11,1739489669,9/16/2015 12:30:01,false,instagc,0.8397,13581319,USA,IL,Trenton,208.70.36.12,ISONIAZID THERAPY treats LATENT TUBERCULOSIS INFECTION,158,136,,186,153,treats,0.979957887012223,803727,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY,TWrex-cause
789214541,9/16/2015 12:43:24,1739493624,9/16/2015 12:42:43,false,clixsense,0.9603,10390268,USA,NY,New Paltz,100.40.133.216,ISONIAZID THERAPY treats LATENT TUBERCULOSIS INFECTION,158,136,,186,153,treats,0.979957887012223,803727,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY,TWrex-cause
789214542,9/16/2015 11:11:02,1739470585,9/16/2015 11:10:33,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
789214542,9/16/2015 11:22:18,1739473690,9/16/2015 11:21:50,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
789214542,9/16/2015 11:28:36,1739474914,9/16/2015 11:27:45,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
789214542,9/16/2015 11:30:36,1739475414,9/16/2015 11:29:41,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
789214542,9/16/2015 11:30:46,1739475452,9/16/2015 11:30:31,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
789214542,9/16/2015 11:33:42,1739476103,9/16/2015 11:33:25,false,clixsense,0.9111,21490235,GBR,N7,Woking,86.30.254.232,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
789214542,9/16/2015 11:40:35,1739477893,9/16/2015 11:33:08,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,RIFAPENTINE treats PULMONARY TUBERCULOSIS,93,29,,114,40,treats,1,800362,"Tam CM, Chan SL, Lam CW et alRIFAPENTINE and isoniazid in the continuation phase of treating PULMONARY TUBERCULOSIS",PULMONARY TUBERCULOSIS,RIFAPENTINE,TWrex-cause
789214543,9/16/2015 14:20:30,1739527414,9/16/2015 14:19:24,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,no_relation,103,46,,114,80,treats,0.480384461415261,800256,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL,TWrex-cause
789214543,9/16/2015 14:37:29,1739533516,9/16/2015 14:36:55,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,no_relation,103,46,,114,80,treats,0.480384461415261,800256,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL,TWrex-cause
789214543,9/16/2015 14:47:47,1739537518,9/16/2015 14:44:52,false,neodev,0.8095,18881135,CAN,ON,Ajax,99.243.87.224,POSTPRANDIAL BLOOD GLUCOSE CONTROL treats HYPOGLYCEMIA,103,46,,114,80,treats,0.480384461415261,800256,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL,TWrex-cause
789214543,9/16/2015 14:58:45,1739541953,9/16/2015 14:57:55,false,clixsense,0.8319,33115750,GBR,I3,Rochester,90.222.106.192,no_relation,103,46,,114,80,treats,0.480384461415261,800256,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL,TWrex-cause
789214543,9/16/2015 15:03:59,1739544289,9/16/2015 15:02:39,false,clixsense,0.675,32049531,USA,VA,Manassas,198.7.59.110,POSTPRANDIAL BLOOD GLUCOSE CONTROL treats HYPOGLYCEMIA,103,46,,114,80,treats,0.480384461415261,800256,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL,TWrex-cause
789214543,9/16/2015 15:10:33,1739546761,9/16/2015 15:09:13,false,neodev,0.6468,33238512,CAN,BC,Langley,205.250.50.224,no_relation,103,46,,114,80,treats,0.480384461415261,800256,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL,TWrex-cause
789214543,9/16/2015 15:49:26,1739571953,9/16/2015 15:49:10,false,instagc,0.7897,33467170,USA,WV,Martinsburg,76.106.109.7,no_relation,103,46,,114,80,treats,0.480384461415261,800256,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL,TWrex-cause
789214544,9/16/2015 18:17:45,1739666390,9/16/2015 18:17:31,false,elite,0.875,31883685,GBR,"","",79.66.244.188,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.995893206467704,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 18:25:34,1739682323,9/16/2015 18:24:54,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,no_relation,262,231,,277,246,treats,0.995893206467704,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 18:29:02,1739690131,9/16/2015 18:28:53,false,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.995893206467704,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 18:56:12,1739757633,9/16/2015 18:54:39,false,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.995893206467704,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 19:08:38,1739773950,9/16/2015 19:07:41,false,neodev,0.704,11026968,CAN,ON,Ottawa,108.168.124.170,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.995893206467704,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 19:28:02,1739783564,9/16/2015 19:27:44,false,clixsense,0.8036,23197581,NLD,11,Den Haag,82.217.6.160,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.995893206467704,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214544,9/16/2015 19:29:47,1739784333,9/16/2015 19:29:39,false,instagc,0.75,16469970,USA,OK,Broken Arrow,72.192.89.181,GLUTEN FREE DIET treats COELIAC DISEASE,262,231,,277,246,treats,0.995893206467704,903747,The 5 HT level in PPP was significantly increased in patients with coeliac disease in whom the disease was untreated or treated with gluten free diet for less than a year (p less than 0.01) but also compared with the patients with COELIAC DISEASE treated with a GLUTEN FREE DIET for more than a year (p less than 0.01.,GLUTEN FREE DIET,COELIAC DISEASE,RO-has_causative_agent
789214545,9/16/2015 15:15:15,1739548831,9/16/2015 15:14:59,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.983078304622849,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 15:43:25,1739569028,9/16/2015 15:43:16,false,prodege,0.7024,14848125,GBR,V8,Airdrie,86.151.77.161,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.983078304622849,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 15:55:12,1739574610,9/16/2015 15:53:49,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.983078304622849,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 16:15:48,1739584107,9/16/2015 16:14:59,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.983078304622849,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 16:17:49,1739584881,9/16/2015 16:17:42,false,neodev,0.3,33373894,USA,TX,Sandy,99.126.198.148,DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS treats RIFAMPICIN,145,90,,183,100,treats,0.983078304622849,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 16:39:03,1739594277,9/16/2015 16:38:50,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.983078304622849,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214545,9/16/2015 16:52:06,1739600659,9/16/2015 16:51:37,false,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,RIFAMPICIN treats DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,145,90,,183,100,treats,0.983078304622849,800095,"Benator D, Bhattacharya M, Bozeman L, et al: Rifapentine and isoniazid once a week versus RIFAMPICIN and isoniazid twice a week for treatment of DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS in HIV negative patients: a randomised clinical trial.",DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS,RIFAMPICIN,TWrex-cause
789214546,9/16/2015 10:15:28,1739454371,9/16/2015 10:14:59,false,neodev,1.0,20306047,GBR,"","",80.41.0.252,DAPSONE treats LEPROMATOUS LEPROSY,11,94,,29,101,treats,0.994134846772434,805169,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE,TWrex-cause
789214546,9/16/2015 10:44:51,1739463037,9/16/2015 10:44:17,false,neodev,0.8806,33758777,USA,"","",38.95.108.251,DAPSONE treats LEPROMATOUS LEPROSY,11,94,,29,101,treats,0.994134846772434,805169,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE,TWrex-cause
789214546,9/16/2015 10:46:09,1739463438,9/16/2015 10:45:42,false,neodev,0.9083,33644825,USA,FL,Fort Lauderdale,65.111.173.161,DAPSONE treats LEPROMATOUS LEPROSY,11,94,,29,101,treats,0.994134846772434,805169,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE,TWrex-cause
789214546,9/16/2015 10:51:17,1739465078,9/16/2015 10:51:04,false,neodev,0.5167,30581619,USA,CA,Laguna Niguel,216.177.129.147,LEPROMATOUS LEPROSY treats DAPSONE,11,94,,29,101,treats,0.994134846772434,805169,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE,TWrex-cause
789214546,9/16/2015 11:01:42,1739468316,9/16/2015 11:01:25,false,elite,0.4385,34356654,USA,DE,"",108.59.11.227,DAPSONE treats LEPROMATOUS LEPROSY,11,94,,29,101,treats,0.994134846772434,805169,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE,TWrex-cause
789214546,9/16/2015 11:04:18,1739469030,9/16/2015 11:03:57,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,DAPSONE treats LEPROMATOUS LEPROSY,11,94,,29,101,treats,0.994134846772434,805169,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE,TWrex-cause
789214546,9/16/2015 11:13:54,1739471435,9/16/2015 11:07:25,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,DAPSONE treats LEPROMATOUS LEPROSY,11,94,,29,101,treats,0.994134846772434,805169,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE,TWrex-cause
789214547,9/16/2015 18:00:15,1739639057,9/16/2015 17:59:42,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 18:17:29,1739665838,9/16/2015 18:16:12,false,elite,0.875,31883685,GBR,"","",79.66.244.188,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 18:24:54,1739680869,9/16/2015 18:23:58,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 18:28:51,1739689631,9/16/2015 18:27:46,false,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 18:54:38,1739753595,9/16/2015 18:53:30,false,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 19:07:40,1739773587,9/16/2015 19:06:53,false,neodev,0.704,11026968,CAN,ON,Ottawa,108.168.124.170,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214547,9/16/2015 19:27:43,1739783440,9/16/2015 19:27:18,false,clixsense,0.8036,23197581,NLD,11,Den Haag,82.217.6.160,[COMBINATION THERAPY] treats [INFLUENZA],155,131,,163,149,treats,0.996815278536125,206855,A 1984 study on complicated influenza had found levamisole to be an effective inducer of interferon and had recommended its use in [COMBINATION THERAPY] for [INFLUENZA].,[INFLUENZA],[COMBINATION THERAPY],TWrex-treat
789214548,9/16/2015 11:31:41,1739475630,9/16/2015 11:31:20,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,SULBACTAM AND AMPICILLIN COMBINATION treats SOFT TISSUE INFECTIONS,90,4,,111,40,treats,0.997054485501581,908272,The SULBACTAM AND AMPICILLIN COMBINATION is an effective combination for the treatment of SOFT TISSUE INFECTIONS,SOFT TISSUE INFECTIONS,SULBACTAM AND AMPICILLIN COMBINATION,RO-may_treat
789214548,9/16/2015 11:34:34,1739476344,9/16/2015 11:34:25,false,clixsense,0.9111,21490235,GBR,N7,Woking,86.30.254.232,SULBACTAM AND AMPICILLIN COMBINATION treats SOFT TISSUE INFECTIONS,90,4,,111,40,treats,0.997054485501581,908272,The SULBACTAM AND AMPICILLIN COMBINATION is an effective combination for the treatment of SOFT TISSUE INFECTIONS,SOFT TISSUE INFECTIONS,SULBACTAM AND AMPICILLIN COMBINATION,RO-may_treat
789214548,9/16/2015 11:34:57,1739476430,9/16/2015 11:33:55,false,clixsense,0.8083,17950689,GBR,L9,Sheffield,146.200.192.103,SULBACTAM AND AMPICILLIN COMBINATION treats SOFT TISSUE INFECTIONS,90,4,,111,40,treats,0.997054485501581,908272,The SULBACTAM AND AMPICILLIN COMBINATION is an effective combination for the treatment of SOFT TISSUE INFECTIONS,SOFT TISSUE INFECTIONS,SULBACTAM AND AMPICILLIN COMBINATION,RO-may_treat
789214548,9/16/2015 11:45:39,1739479158,9/16/2015 11:45:23,false,prodege,0.7014,22031444,GBR,F2,Gosport,92.24.223.243,SULBACTAM AND AMPICILLIN COMBINATION treats SOFT TISSUE INFECTIONS,90,4,,111,40,treats,0.997054485501581,908272,The SULBACTAM AND AMPICILLIN COMBINATION is an effective combination for the treatment of SOFT TISSUE INFECTIONS,SOFT TISSUE INFECTIONS,SULBACTAM AND AMPICILLIN COMBINATION,RO-may_treat
789214548,9/16/2015 11:50:46,1739480438,9/16/2015 11:50:28,false,zoombucks,0.7833,4711962,CAN,ON,Markham,174.88.29.138,SULBACTAM AND AMPICILLIN COMBINATION treats SOFT TISSUE INFECTIONS,90,4,,111,40,treats,0.997054485501581,908272,The SULBACTAM AND AMPICILLIN COMBINATION is an effective combination for the treatment of SOFT TISSUE INFECTIONS,SOFT TISSUE INFECTIONS,SULBACTAM AND AMPICILLIN COMBINATION,RO-may_treat
789214548,9/16/2015 12:02:56,1739483236,9/16/2015 12:02:28,false,prodege,0.8139,27934334,GBR,C8,Croydon,81.159.60.206,SULBACTAM AND AMPICILLIN COMBINATION treats SOFT TISSUE INFECTIONS,90,4,,111,40,treats,0.997054485501581,908272,The SULBACTAM AND AMPICILLIN COMBINATION is an effective combination for the treatment of SOFT TISSUE INFECTIONS,SOFT TISSUE INFECTIONS,SULBACTAM AND AMPICILLIN COMBINATION,RO-may_treat
789214548,9/16/2015 12:12:53,1739485750,9/16/2015 12:12:12,false,clixsense,0.7481,19638651,USA,SC,Summerville,174.107.73.211,SULBACTAM AND AMPICILLIN COMBINATION treats SOFT TISSUE INFECTIONS,90,4,,111,40,treats,0.997054485501581,908272,The SULBACTAM AND AMPICILLIN COMBINATION is an effective combination for the treatment of SOFT TISSUE INFECTIONS,SOFT TISSUE INFECTIONS,SULBACTAM AND AMPICILLIN COMBINATION,RO-may_treat
789214549,9/16/2015 09:35:27,1739442925,9/16/2015 09:29:47,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
789214549,9/16/2015 09:43:54,1739445098,9/16/2015 09:43:35,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,no_relation,84,13,,90,23,treats,0.351123441588392,903897,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
789214549,9/16/2015 09:50:01,1739446484,9/16/2015 09:48:35,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,CANDIDA treats CANDIDEMIA,84,13,,90,23,treats,0.351123441588392,903897,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
789214549,9/16/2015 09:52:48,1739447322,9/16/2015 09:52:28,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,no_relation,84,13,,90,23,treats,0.351123441588392,903897,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
789214549,9/16/2015 09:53:21,1739447426,9/16/2015 09:52:57,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,no_relation,84,13,,90,23,treats,0.351123441588392,903897,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
789214549,9/16/2015 10:03:19,1739450575,9/16/2015 10:02:03,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,no_relation,84,13,,90,23,treats,0.351123441588392,903897,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
789214549,9/16/2015 10:03:55,1739450789,9/16/2015 10:03:44,false,clixsense,0.4905,19162475,GBR,P8,Trowbridge,82.33.126.30,CANDIDEMIA treats CANDIDA,84,13,,90,23,treats,0.351123441588392,903897,Treatment of CANDIDEMIA is more complicated because of the changing epidemiology of CANDIDA and introduction of newer antifungal agents.,CANDIDA,CANDIDEMIA,RO-has_causative_agent
789214550,9/16/2015 15:15:15,1739548828,9/16/2015 15:14:59,false,neodev,0.6677,33701549,AUS,02,Sydney,103.238.131.137,BRADYCARDIA treats NEOSTIGMINE,142,36,,153,47,treats,0.8571428571,223003,"It is also used in conjunction with [NEOSTIGMINE], a neuromuscular blocking reversal agent, to prevent neostigmine's muscarinic effects such as [BRADYCARDIA].",BRADYCARDIA,NEOSTIGMINE,TWrex-treat
789214550,9/16/2015 15:43:25,1739569009,9/16/2015 15:43:16,false,prodege,0.7024,14848125,GBR,V8,Airdrie,86.151.77.161,NEOSTIGMINE treats BRADYCARDIA,142,36,,153,47,treats,0.8571428571,223003,"It is also used in conjunction with [NEOSTIGMINE], a neuromuscular blocking reversal agent, to prevent neostigmine's muscarinic effects such as [BRADYCARDIA].",BRADYCARDIA,NEOSTIGMINE,TWrex-treat
789214550,9/16/2015 15:55:12,1739574618,9/16/2015 15:53:49,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,NEOSTIGMINE treats BRADYCARDIA,142,36,,153,47,treats,0.8571428571,223003,"It is also used in conjunction with [NEOSTIGMINE], a neuromuscular blocking reversal agent, to prevent neostigmine's muscarinic effects such as [BRADYCARDIA].",BRADYCARDIA,NEOSTIGMINE,TWrex-treat
789214550,9/16/2015 16:15:48,1739584105,9/16/2015 16:14:59,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,NEOSTIGMINE treats BRADYCARDIA,142,36,,153,47,treats,0.8571428571,223003,"It is also used in conjunction with [NEOSTIGMINE], a neuromuscular blocking reversal agent, to prevent neostigmine's muscarinic effects such as [BRADYCARDIA].",BRADYCARDIA,NEOSTIGMINE,TWrex-treat
789214550,9/16/2015 16:17:49,1739584880,9/16/2015 16:17:42,false,neodev,0.3,33373894,USA,TX,Sandy,99.126.198.148,BRADYCARDIA treats NEOSTIGMINE,142,36,,153,47,treats,0.8571428571,223003,"It is also used in conjunction with [NEOSTIGMINE], a neuromuscular blocking reversal agent, to prevent neostigmine's muscarinic effects such as [BRADYCARDIA].",BRADYCARDIA,NEOSTIGMINE,TWrex-treat
789214550,9/16/2015 16:39:03,1739594281,9/16/2015 16:38:50,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,NEOSTIGMINE treats BRADYCARDIA,142,36,,153,47,treats,0.8571428571,223003,"It is also used in conjunction with [NEOSTIGMINE], a neuromuscular blocking reversal agent, to prevent neostigmine's muscarinic effects such as [BRADYCARDIA].",BRADYCARDIA,NEOSTIGMINE,TWrex-treat
789214550,9/16/2015 16:52:06,1739600664,9/16/2015 16:51:37,false,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,NEOSTIGMINE treats BRADYCARDIA,142,36,,153,47,treats,0.8571428571,223003,"It is also used in conjunction with [NEOSTIGMINE], a neuromuscular blocking reversal agent, to prevent neostigmine's muscarinic effects such as [BRADYCARDIA].",BRADYCARDIA,NEOSTIGMINE,TWrex-treat
789214551,9/16/2015 11:10:32,1739470485,9/16/2015 11:10:18,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:20:13,1739473228,9/16/2015 11:20:05,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:21:49,1739473589,9/16/2015 11:21:20,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:27:44,1739474717,9/16/2015 11:27:12,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,no_relation,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:29:39,1739475185,9/16/2015 11:28:45,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:30:30,1739475389,9/16/2015 11:29:41,false,fusioncash,0.9194,31742806,USA,OH,Kent,66.61.82.242,PHENYTOIN treats POST-TRAUMATIC EPILEPSY,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214551,9/16/2015 11:33:05,1739475966,9/16/2015 11:29:51,false,points4rewards,0.7956,20113482,USA,PA,Philadelphia,162.208.49.45,no_relation,64,11,,87,20,treats,0.99654575824488,907396,The use of PHENYTOIN in headache syndromes and in prevention of POST-TRAUMATIC EPILEPSY is discussed,POST-TRAUMATIC EPILEPSY,PHENYTOIN,RO-may_prevent
789214552,9/16/2015 17:54:22,1739632154,9/16/2015 17:53:53,false,prodege,0.8853,6309240,USA,CA,San Diego,205.241.40.254,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
789214552,9/16/2015 17:59:41,1739638255,9/16/2015 17:59:22,false,prodege,0.8929,13300986,CAN,AB,Edmonton,68.150.40.134,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
789214552,9/16/2015 18:16:11,1739663427,9/16/2015 18:15:52,false,elite,0.875,31883685,GBR,"","",79.66.244.188,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
789214552,9/16/2015 18:23:57,1739678882,9/16/2015 18:23:28,false,prodege,0.8383,21417560,GBR,C3,Cambridge,151.224.120.191,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
789214552,9/16/2015 18:27:44,1739687058,9/16/2015 18:27:22,false,prodege,0.7438,1924522,USA,NY,New York,96.224.4.120,RECURRENT VENOUS THROMBOEMBOLISM treats CONVENTIONAL INTENSITY WARFARIN THERAPY,118,50,,149,89,treats,0.995037190209989,907299,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
789214552,9/16/2015 18:53:29,1739750505,9/16/2015 18:52:37,false,clixsense,0.769,33878524,CAN,BC,Princeton,75.156.83.71,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
789214552,9/16/2015 19:06:52,1739773254,9/16/2015 19:06:18,false,neodev,0.704,11026968,CAN,ON,Ottawa,108.168.124.170,CONVENTIONAL INTENSITY WARFARIN THERAPY treats RECURRENT VENOUS THROMBOEMBOLISM,118,50,,149,89,treats,0.995037190209989,907299,Comparison of low intensity warfarin therapy with CONVENTIONAL INTENSITY WARFARIN THERAPY for long term prevention of RECURRENT VENOUS THROMBOEMBOLISM,RECURRENT VENOUS THROMBOEMBOLISM,CONVENTIONAL INTENSITY WARFARIN THERAPY,RO-may_prevent
789214553,9/16/2015 15:55:39,1739574789,9/16/2015 15:55:13,false,prodege,0.9181,24945126,GBR,K8,Ilford,82.12.220.44,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 16:16:15,1739584229,9/16/2015 16:15:52,false,points4rewards,0.9083,28703583,USA,"","",184.53.32.62,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 16:39:15,1739594339,9/16/2015 16:39:03,false,elite,0.8889,30064988,GBR,B4,Bradford,92.22.135.111,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 16:52:18,1739600724,9/16/2015 16:52:07,false,instagc,0.8619,26024737,GBR,A9,Blackpool,92.23.159.7,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 16:52:20,1739600730,9/16/2015 16:52:13,false,prodege,0.2,2143114,CAN,BC,Vancouver,24.85.153.181,INFLAMMATION treats HYDROCORTISONE,158,124,,169,138,treats,0.983869910099907,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 17:12:53,1739610906,9/16/2015 17:12:45,false,superrewards,0.8333,33199643,USA,WI,La Crosse,138.49.2.136,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214553,9/16/2015 17:24:23,1739615931,9/16/2015 17:23:54,false,clixsense,0.9276,20587495,CAN,NL,St. John's,142.162.227.3,HYDROCORTISONE treats INFLAMMATION,158,124,,169,138,treats,0.983869910099907,908222,Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and HYDROCORTISONE in suppressing the INFLAMMATION,INFLAMMATION,HYDROCORTISONE,RO-may_treat
789214554,9/16/2015 09:38:17,1739443708,9/16/2015 09:37:29,false,clixsense,1.0,30681826,GBR,I9,Diss,31.49.71.254,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 09:44:40,1739445215,9/16/2015 09:44:27,false,instagc,0.9583,18960682,GBR,U2,Annan,92.18.213.181,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 09:51:53,1739446964,9/16/2015 09:50:51,false,gifthulk,0.9722,24928180,GBR,M1,Slough,90.206.237.191,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 09:54:06,1739447674,9/16/2015 09:53:52,false,neodev,0.6667,14096345,NLD,03,Eibergen,178.85.94.186,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 09:54:08,1739447688,9/16/2015 09:53:45,false,meprizescf,0.8167,28483210,USA,WI,Minocqua,75.143.134.247,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 10:05:59,1739451528,9/16/2015 10:04:57,false,neodev,0.6746,31988911,USA,CA,Saratoga,107.178.37.2,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214554,9/16/2015 10:11:51,1739453277,9/16/2015 10:11:29,false,pocketmoneygpt,0.9643,21432964,GBR,F8,Borehamwood,81.159.185.70,KETOPROFEN treats RHEUMATOID ARTHRITIS,130,82,,150,92,treats,1,907589,"El-Ghobarey AF, Rennie JAN, Hadidi T et al. A comparative trial of large doses of KETOPROFEN and indomethacin in the treatment of RHEUMATOID ARTHRITIS",RHEUMATOID ARTHRITIS,KETOPROFEN,RO-may_treat
789214555,9/16/2015 11:05:41,1739469389,9/16/2015 11:05:15,false,clixsense,0.9048,24104564,AUS,02,Surry Hills,60.241.245.92,FLUCONAZOLE treats NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,98,44,,141,55,treats,1,800929,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE,TWrex-cause
789214555,9/16/2015 11:10:17,1739470438,9/16/2015 11:10:02,false,clixsense,0.875,32053717,GBR,"","",51.174.76.80,FLUCONAZOLE treats NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,98,44,,141,55,treats,1,800929,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE,TWrex-cause
789214555,9/16/2015 11:20:04,1739473184,9/16/2015 11:19:47,false,bitcoinget,0.9083,31256687,USA,NY,Brooklyn,24.146.181.193,FLUCONAZOLE treats NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,98,44,,141,55,treats,1,800929,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE,TWrex-cause
789214555,9/16/2015 11:21:18,1739473466,9/16/2015 11:20:36,false,neodev,0.8264,31326282,NLD,"","",82.169.243.65,FLUCONAZOLE treats NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,98,44,,141,55,treats,1,800929,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE,TWrex-cause
789214555,9/16/2015 11:27:11,1739474579,9/16/2015 11:26:49,false,keeprewarding,0.8204,29139615,CAN,ON,Perth,192.186.81.178,FLUCONAZOLE treats NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,98,44,,141,55,treats,1,800929,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE,TWrex-cause
789214555,9/16/2015 11:27:18,1739474601,9/16/2015 11:27:13,false,elite,0.5833,33798502,USA,DE,"",108.59.8.208,FLUCONAZOLE treats NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,98,44,,141,55,treats,1,800929,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE,TWrex-cause
789214555,9/16/2015 11:28:43,1739474957,9/16/2015 11:27:56,false,gifthunterclub,0.8694,24043308,GBR,"","",94.102.147.250,FLUCONAZOLE treats NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,98,44,,141,55,treats,1,800929,"Catanzaro A, Galgiani JN, Levine BE, et al: FLUCONAZOLE in the treatment of chronic pulmonary and NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS",NONMENINGEAL DISSEMINATED COCCIDIOIDOMYCOSIS,FLUCONAZOLE,TWrex-cause
789214556,9/16/2015 12:47:33,1739495082,9/16/2015 12:47:15,false,bitcoinget,0.9375,30546513,GBR,G6,Hull,194.42.67.50,IMMEDIATE RELEASE LEVODOPA treats PD,278,213,,279,239,treats,0.866025403784439,907810,STUDY SELECTION  English language studies were selected if they evaluated the neuroprotective effects or safety of selegiline or if they compared dopamine agonists with levodopa or sustained release levodopa with IMMEDIATE RELEASE LEVODOPA in previously untreated patients with PD,PD,IMMEDIATE RELEASE LEVODOPA,RO-may_treat
789214556,9/16/2015 13:33:22,1739509735,9/16/2015 13:29:27,false,clixsense,0.6944,21875134,GBR,"","",80.189.12.98,IMMEDIATE RELEASE LEVODOPA treats PD,278,213,,279,239,treats,0.866025403784439,907810,STUDY SELECTION  English language studies were selected if they evaluated the neuroprotective effects or safety of selegiline or if they compared dopamine agonists with levodopa or sustained release levodopa with IMMEDIATE RELEASE LEVODOPA in previously untreated patients with PD,PD,IMMEDIATE RELEASE LEVODOPA,RO-may_treat
789214556,9/16/2015 14:01:36,1739520815,9/16/2015 14:01:15,false,clixsense,0.8393,6340330,USA,NY,Canajoharie,67.248.115.74,IMMEDIATE RELEASE LEVODOPA treats PD,278,213,,279,239,treats,0.866025403784439,907810,STUDY SELECTION  English language studies were selected if they evaluated the neuroprotective effects or safety of selegiline or if they compared dopamine agonists with levodopa or sustained release levodopa with IMMEDIATE RELEASE LEVODOPA in previously untreated patients with PD,PD,IMMEDIATE RELEASE LEVODOPA,RO-may_treat
789214556,9/16/2015 14:16:23,1739525973,9/16/2015 14:15:05,false,gifthulk,0.8833,18666417,USA,PA,Meadville,24.101.32.13,no_relation,278,213,,279,239,treats,0.866025403784439,907810,STUDY SELECTION  English language studies were selected if they evaluated the neuroprotective effects or safety of selegiline or if they compared dopamine agonists with levodopa or sustained release levodopa with IMMEDIATE RELEASE LEVODOPA in previously untreated patients with PD,PD,IMMEDIATE RELEASE LEVODOPA,RO-may_treat
789214556,9/16/2015 14:20:40,1739527487,9/16/2015 14:20:18,false,points4rewards,0.7119,20306700,USA,WA,Bothell,50.106.46.70,IMMEDIATE RELEASE LEVODOPA treats PD,278,213,,279,239,treats,0.866025403784439,907810,STUDY SELECTION  English language studies were selected if they evaluated the neuroprotective effects or safety of selegiline or if they compared dopamine agonists with levodopa or sustained release levodopa with IMMEDIATE RELEASE LEVODOPA in previously untreated patients with PD,PD,IMMEDIATE RELEASE LEVODOPA,RO-may_treat
789214556,9/16/2015 14:29:44,1739530594,9/16/2015 14:29:20,false,onestopgpt,0.8333,21275875,CAN,ON,Hamilton,24.36.124.79,IMMEDIATE RELEASE LEVODOPA treats PD,278,213,,279,239,treats,0.866025403784439,907810,STUDY SELECTION  English language studies were selected if they evaluated the neuroprotective effects or safety of selegiline or if they compared dopamine agonists with levodopa or sustained release levodopa with IMMEDIATE RELEASE LEVODOPA in previously untreated patients with PD,PD,IMMEDIATE RELEASE LEVODOPA,RO-may_treat
789214556,9/16/2015 14:34:49,1739532522,9/16/2015 14:33:55,false,points4rewards,0.7123,28755767,USA,VA,Chester,68.57.118.32,IMMEDIATE RELEASE LEVODOPA treats PD,278,213,,279,239,treats,0.866025403784439,907810,STUDY SELECTION  English language studies were selected if they evaluated the neuroprotective effects or safety of selegiline or if they compared dopamine agonists with levodopa or sustained release levodopa with IMMEDIATE RELEASE LEVODOPA in previously untreated patients with PD,PD,IMMEDIATE RELEASE LEVODOPA,RO-may_treat
